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ABSTRACT 
The regulation of proteolytic enzymes in tissues by endogenous inhibitors 
is a critical requirement in the maintenance of homeostasis. These inhibitiors are 
found primarily in blood plasma and after albumins and immonoglobulins, fliey 
constitute by weight the third largest group (10%) of fimctional proteins. Vast 
majorit>' of these inhibitors is targeted towards serine proteinases known to be inv-
olved in phagocytosis, coagulation, complement activation and fibrinolysis, aianti-
tr>'psin is one of the most important serine proteinase inhibitor present in mamma-
lian plasma. Human alpha-1-antitrypsin has been the subject of intense investiga-
tions because of the fact that it plays a ver)' important role in controlling various 
proteolytic events in tissues. Several mammalian plasma ai antitrypsin have been 
isolated and characterized e.g. human, dog, horse, rabbit, goat, sheep, etc. and we-
re generally found to differ either physicochemically or in their inhibitory specific-
ities towards various proteinases. The desirability' of getting some relevant inform-
ations, Oiantitrypsin has been isolated and characterized from hitherto uninves-
tigated source i.e., buffalo senun and data obtained ha\e been presented in this 
thesis. 
Buffalo serum aiantitrypsin was isolated by salt fractionation method 
using ammonium sulphate and was further purified by ion exchange chromatogra-
phy via DEAE-Sephacel column using 0.03 M sodium phosphate buffer, pH 6.8, 
Is = 0.042. The protein was eluted batvsise with buffer of varying ionic strengths 
( Is = 0.042, 0.1, 0.2. 0.5 and 1.0 ). The fractions eluted with buffer of Is = 0.2 
were pooled and assa>'ed for antitryptic activity and was found to be maximum. 
Native PAGE pattern of the pooled fraction showed the presence of some impuri-
ties The pooled fractions were rechromatographed on the same ion exchange 
column under identical conditions. The rechromatographed pooled fractions were 
found to be free from impurities and homogeneit>' with respect to charge was con-
firmed by the presence of a single sharp band on 10% gel when native polyacryl-
amide gel electrophoresis was performed in the same conditions as before (Tris 
glycine buffer, pH 8.3). 
Buffalo serum ai antitrypsin was found to be homogeneous with respect to 
size when electrophoresed on 10% gel using Tris glycine buffer, pH 8.3 containing 
0.1% SDS. That the inhibitor isolated in this study was homogeneous with respect 
to size was further confirmed by presence of a single s>Tnmetrical peak obtained 
during gel filtration on Sephacryl S-200 HR colunm and also during HPLC gel 
filtration. 
Molecular weight of buffalo serum ajantitry^jsin isolated in this study 
determined by SDS-PAGE was found to be 51KDa when the relative mobility of 
the inhibitor was compared with the relatives mobilities of the markers proteins 
xiz bovine serum albumin dimer, bovine serum albumin monomer, ovalbumin, a-
ch>Tnotrypsinogen and c>1ochrome c. Presence of single homogeneous band and 
no alteration in the relative mobilit> values during electrophoresis both under redu-
cing and non-reducmg conditions suggested that the isolated buffalo serum aianti-
tr>'psin consisted of a single polypeptide chain 
Buffalo serum ai antitrypsin was found to be sialoglycoprotein containing 
about 2.6% sialic acid and 10.9% neutral hexoses. The inhibitor was found to 
contain two free sulphy dr> 1 groups as shovvTi by DTNB titration. 
The specific extinction coefficient of buffalo serum aiantitrypsin was co-
mputed from the optical densities of protein solutions of known concentration and 
was found to be 5.05 cm' g ' at 280 nm. 
Functional analysis of buffalo serum aiantitrypsin was carried out by det-
ermining the casienolytic activit>' of proteinases \iz. bovine trypsin, porcine pancr-
eatic elastase and bovine chymotr>'psin in the presence of varying amount of the 
inhibitor. It was found that at inhibitor enzyme ratio of 1:1 the inhibition of case-
inolytic acti\it> of trypsin was 85%, while the corresponding inhibition of the 
acti\it> of elastase was about 65% under identical conditions. Interestingly it was 
obser\'ed that the buffalo serum O] antitrypsin acts as a poor inhibitor of the casein-
ol>'tic actiMt\ of bo\ine chyTnotr^psin (36%) at inhibitor enzyme ratio of 1:1. 
Hence, functionally buffalo serum a]antitr>'psin can be said to be different from 
human aiantitrypsin. 
Hydrod>Tiamic properties of buffalo serum aiantitrypsin isolated in this 
thesis were determined b>' gel filtration on Sephacr>'l S-200HR column. The res-
ults obtained gave a value 3.23 nm for the stokes radius of the inhibitor. The diff-
usion coefficient was found to be 6.85 x 10" cm' s' and frictional ratio was found 
to be 1.27 which together suggested a slightl> aglobular conformation and exces-
sive hydration of the isolated inhibitor molecules. The latter explanation seems 
plausible as the isolated inhibitor was found to be a sialoglycoprotein containing 
about 13.S**© carbohydrate Because of the glycoproteinic nature of the isolated 
inhibitor the molecular weight obtained by gel filtration (56.4 KDa) was higher 
than the molecular weight obtained by SDS-PAGE (51 KDa). 
The inhibitory activit> measurements of buffalo serum a)antitr>'psin at 
increasing urea and guanidine hydiochloride concentration show a gradual decrea-
se in the antitryptic acti\it> of the inhibitor with an increase in urea concentration, 
still retaining some of its inhibitory acti\ity (22" o) even at 9M urea concentration. 
.-MtematiNcly, the inhibitor showed an abrupt decrease in its activit>' as the concen-
tration of guanidine hydrochloride was increased finally reaching zero at about 5M 
guanidine hydrochloride concentration. The results suggested that the inhibitor 
isolated in this thesis has a rigid structure and also that guanidine hydrochloride 
acts as more potent denaturant than urea. 
That the isolated buffalo serum ai antitrypsin is a tryptophan containing 
protein was studied by UV spectroscopy, solvent perturbation difference spectra 
and fluorescence spectroscopy. The UV absorption spectra of the inhibitor in 9M 
urea showed a distinct blue shift as compared to native inhibitor characteristic of 
conformational changes taking place in the buffalo serum ai antitrypsin. Denatu-
ration in 9M urea and consequent exposure of tyrosyl residues was indicated in the 
difference spectrum by the presence of clear cut trough at 286 nm while the abse-
nce of any feature in the 290-292 nm range indicated no change in the environ-
ment of tryptophan residues. As observed during activity measurements that the 
inhibitor has a rigid structure and resistant to denaturation even at 9M urea was 
further confirmed by the presence of a clear cut trough at 286 nm and also the 
presence of a trough in 290-292nm range in the difference spectra obtained by 
denaturation in 6M guanidine hydrochloride which were also suggestive of the 
exposed nature of both tyrosine and tryptophan residues present in buffalo serum 
a 1 antitrypsin. 
Solvent perturbation difference spectra obtained by denaturation in 9M 
urea using 20% (v/v) dimethyl sulphoxide indicated about 48% exposure of trypto-
phan residues while the spectra obtained by denaturation in 6M guanidine hydro-
chloride indicated 75% exposure of tryptophan residues in the native buffalo 
serum ai antitrypsin. 
Fluorescence results showed that the native inhibitor had an emission 
maxima of 336 nm using excitation wavelength of 276 nm which indicated the 
presence of tryptophan residues. The tryptophan fluorescence results showed a 
distinct blue shift of the emission maxima of inhibitor to 335 nm in 9M urea while 
a red diift of die emission maxima of inhibitor to 345 nm in 6M guanidine 
hydrochloride compared to native inhibitor emission maxima of 337 mn. The red 
shift in emission maxima obtained was indicative of the exposure of tryptophan 
residues to tibc aqueous environment. That of the two guanidine hydrochloride acts 
as a potent denaturant has also been shown by the fluorescence intensity meas-
urements at varying urea and guanidine hydrochloride concentration. The fluore-
scence intenaty was found to decrease and the inhibitor denatured in 6M guani-
dine hydrochloride had the lowest fluorescence intensity. 
Denaturation curve analysis of buffalo serum aiantitrypsin at varying con-
centration of urea and guanidine hydrochloride show no change in the fo values 
upto about 2.0M urea and 1.2M guanidine hydrochloride concentration followed 
by a transition which was steep and gradual suggesting noncooperative nature of 
the process of unfolding. The A GD 2 value (3.17 Kcal/ mole) obtained in case of 
urea denatured inhibitor was found to be in excellent agreement with the value of 
A GD"2^ (3.42 Kcal/ mole) obtained in case of guanidine hydrochloride denatured 
inhibitor irrespective of the fact that guanidine hydrochloride acts as more potent 
denaturant than urea. Thus the various denaturation studies (activity profile, UV 
difference spectroscopy, fluorescence measurements) show the relative elBfective-
ness of these two denaturants on buffalo serum ai antitrypsin and also that the inhi-
bitor has a fairly rigid structure as observed by its capacity to retain some of its 
inhibitory activity even at 9M urea concentration. It was also observed that the 
denaturation of buffalo serum a 1 antitrypsin in guanidine hydrochloride was comp-
lete at a littie more than half the concentration as compared to urea. 
CD spectrum of native buffalo serum aiantitrypsin showed the presence 
of both tiie a helical and P-pleated sheet structure. While the CD spectrum of the 
inhibitor denatured in 9M urea show a decrease in negative eUipticity indicating 
some changes in the backbone conformation. The CD spectrum of inhibitor dena-
tured in 6M guanidine hydrochloride shows a fully denatured backbone conforma-
tion. 
The isolated buffalo serum aj antitrypsin was competitive in nature as it 
was found to inhibit trypsin completely at en2yme inhibitor molar ratio of 1:1 and 
the competitive nature was further confirmed by the kinetic parameter (Km and 
Vmax) values determined by double reciprocal plot. 
that: 
It can be concluded on the basis of the studies carried out in this thesis 
(i) Buffalo serum Oi antitrypsin has been isolated and purified by a very 
simple and gentle procedure. No extremes of pH or temperature, no expo-
sure to solvents distinguish this from previously reported methods. 
(ii) Buffalo serum oi antitrypsin obtained, satisfies many criteria of homogen-
eity as it was found to be homogeneous both with respect to charge 
and size as shown by ion exchange chromatography, PAGE, SDS-PAGE, 
gel chromatography on Sephacryl S-200HR column as well as during 
HPLC gel filtration. 
(iii) The presence of a single band during SDS-PAGE both under reducing and 
non-reducing conditions predict a single chain structure of the native mol-
ecule. 
(iv) Buffalo serum ai antitrypsin was found to contain two free sulphydryl 
groups. 
(v) Buffalo serum ai antitrypsin was observed to be a sialoglycoprotein conta-
ining about 2.6% sialic acid and 10.9% neutral hexose. 
(vi) Buifalo serum ai antitrypsin showed inhibitory q)ecificity different from 
human aiantitrypsin. The former was observed to be a potent inhibitor 
of bovine trypsin and only a moderate inhibitor of elastase while the latter 
has been reported in earlier studies to be a potent inhibitor of elastase. The 
difference in the inhibitory specificities can be due to the differences in 
the amino acid sequence within the reactive site region. 
(vii) biterestingly, it Avas observed that though the buffalo serum aiantitrypsin 
contains both neutral hexose and sialic acid residues like its human coun-
terpart (reported in earlier studies), it (buffalo serum aiantitrypsin) shows 
inhibitory specificity different from human aiantitrypsin but similar to 
goat ai PI which has been reported earlier to be a glycoprotein devoid of 
sialic acid residue. Thus it can be said that sialic acid residues have no 
role to play in deciding the inhibitory behaviour of the inhibitor. 
(viii) Molecular weight of buffalo serum aiantitrypsin obtained by gel filtration 
was found to be about 9% higher than the molecular weight obtained by 
SDS-PAGE which can be attributed to the high content of carbohydrate 
residues in the molecule. 
(ix) UV difference spectra of buffalo serum aiantitrypsin obtained with urea 
or guanidine hydrochloride indicate that tryptophan residues were not e}q)-
osed when denatiued in urea but were exposed when guanidine hydrochl-
oride was used Thus guanidine hydrochloride can be said to be a more 
potent denaturant 
(x) Solven perturbation difference spectra indicate that irrespective of the den-
aturant used the tryptophan residues were only partially accessible to the 
solvent. The accessibility increases when guanidine hydrochloride was 
used as a denaturant. 
(xi) Tryptophan fluorescence results confirmed the conclusion derived from 
UV spectrum and solvent perturbation analysis. Denaturation of buifalo 
serum aiantitrypsin in 6M guanidine hydrochloride was observed to lead 
to a large red shift in the emission maxima as well as decrease in fluoresc-
ence intensity which were indicative of major conformational changes in 
the surrounding of the chromophore (exposure of tryptophan residues to 
the aqueous environment in the unfolded state). Similar results were obta-
ined when fluorescence intensity of the inhibitor was monitored at 337nm 
in the presence of varying amount of urea and guanidine hydrochloride. 
(xii) Of substantia] interest was the observation that inspite of guanidine hydro-
chloride being a more potent denaturant AGD"2° values obtamed both in 
case of urea and guanidine hydrochloride were found to be in excellent 
agreement. It was also observed that denaturation of inhibitor in guanidine 
hydrochloride was complete at a little more than half the concentration as 
compared to urea. 
(xiii) CD spectra of native buffalo serum QJ antitrypsin compared with 9M urea 
denatured aiantitrypsin and 6M guanidine hydrochloride denatured aiant-
itrypsin indicate that the native molecule consists of a high content of a-
helical and p-pleated sheet structure while the backbone conformation 
was slightly disorganised in 9M urea further it was also observed that the 
backbone conformation was fiilly disorganised in 6M guanidine hydrochl-
oride. 
'^ 
(xiv) The results obtained during UV spectroscopy, activity measurements (in 
the presence of denaturants), solvent perturbation studies, fluorescence 
measurements, denaturation curve analysis and CD measurements indica-
ted that the buffalo serum ai antitrypsin has a fairly rigid and stable struct-
ure. 
(xv) That the buffalo serum ai antitrypsin acts as a competitive inhibitor has 
been been shown by the stoichiometric analysis of the inhibitor binding to 
trypsin in 1 . 1 ratio as well as from the values of kinetic parameters 
(Km and Vmax) obtained by double reciprocal plot. 
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ABSTRACT 
The regulation of proteolytic enzymes in tissues by endogenous inhibitors 
is a critical requirement in the maintenance of homeostasis. These inhibitiors are 
found primarily in blood plasma and after albumins and immonoglobulins, they 
constitute by weight the third largest group (10%) of functional proteins. Vast 
majority of these inhibitors is targeted towards serine proteinases known to be inv-
olved in phagocytosis, coagulation, complement activation and fibrinolysis, aianti-
tr>'psin is one of the most important serine proteinase inhibitor present in mamma-
lian plasma. Human alpha-1-antitrypsin has been the subject of intense investiga-
tions because of the fact that it plays a very important role in controlling various 
proteolytic events in tissues. Several mammalian plasma aj antitrypsin have been 
isolated and characterized e.g. human, dog, horse, rabbit, goat, sheep, etc. and we-
re generally found to differ either physicochemically or in their inhibitory specific-
ities towards various proteinases. The desirability of getting some relevant inform-
ations, ttiantitrypsin has been isolated and characterized from hitherto uninves-
tigated source i.e., buffalo serum and data obtained have been presented in this 
thesis. 
Buffalo serum ai antitrypsin was isolated by salt fractionation method 
using ammonium sulphate and was further purified by ion exchange chromatogra-
phy via DEAE-Sephacel column using 0.03 M sodium phosphate buffer, pH 6.8, 
Is = 0.042. The protein was eluted batwise with buffer of varying ionic strengths 
( Is = 0.042, 0.1, 0.2, 0.5 and 1.0 ). The fractions eluted with buffer of Is = 0.2 
were pooled and assayed for antitryptic activity and was found to be maximum. 
Native PAGE pattern of the pooled fraction showed the presence of some impuri-
ties. The pooled fractions were rechromatographed on the same ion exchange 
column under identical conditions. The rechromatographed pooled fractions were 
found to be free from impurities and homogeneity with respect to charge was con-
firmed by the presence of a single sharp band on 10% gel when native polyacryl-
amide gel electrophoresis was performed in the same conditions as before (Tris 
glycine buffer, pH 8.3). 
Buffalo serum ajantitrypsm was found to be homogeneous with respect to 
size when electrophoresed on 10% gel using Tris glycme buffer, pH 8.3 containing 
0.1% SDS. That the inhibitor isolated in this study was homogeneous with respect 
to size was further confirmed by presence of a single s>TmTietrical peak obtained 
during gel filtration on Sephacr\'l S-200 HR column and also during HPLC gel 
filtration. 
Molecular weight of buffalo serum ajantitrypsin isolated in this study 
determined by SDS-PAGE was found to be 51KDa when the relative mobility of 
the inhibitor was compared with the relatives mobilities of the markers proteins 
viz. bovine serum albumin dimer. bovine serum albumin monomer, ovalbumin, a-
ch^TUOtrypsinogen and cytochrome c. Presence of smgle homogeneous band and 
no alteration in the relative mobilit> values during electrophoresis both under redu-
cing and non-reducing conditions suggested that the isolated buffalo serum O)anti-
trypsin consisted of a single polypeptide chain. 
Buffalo serum aj antitrypsin was found to be sialoglycoprotein containing 
about 2.6% sialic acid and 10.9% neutral hexoses. The inhibitor was found to 
contain two free sulphydryl groups as shown by DTNB titration. 
The specific extinction coefficient of buffalo serum ai antitrypsin was co-
mputed from the optical densities of protein solutions of known concentration and 
was found to be 5.05 cm^ g ' at 280 nm. 
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Functional analysis of buffalo serum ai antitrypsin was carried out by det-
ermining the casienolytic activity of proteinases viz. bovine trypsin, porcine pancr-
eatic elastase and bovine chymotrypsin in the presence of varying amount of the 
inhibitor . It was found that at inhibitor enzyme ratio of 1; 1 the inhibition of case-
inolytic activity of trypsin was 85%, while the corresponding inhibition of the 
activit>' of elastase was about 65% under identical conditions. Interestingly it was 
observed that the buffalo serum aiantitrypsin acts as a poor inhibitor of the casein-
olytic acti\nty of bovine chymotrypsin (36%) at inhibitor enzyme ratio of 1;1. 
Hence, functionally buffalo serum aiantitrypsin can be said to be different from 
human aiantitrypsin. 
Hydrod>Tiamic properties of buffalo serum aiantitrypsin isolated in this 
thesis were determined by gel filtration on Sephacryl S-200HR column. The res-
ults obtained gave a value 3.23 nm for the stokes radius of the inhibitor. The diff-
usion coefficient was found to be 6.85 x 10" cm"^  s ' and frictional ratio was found 
to be 1.27 which together suggested a slightK aglobular conformation and exces-
sive h>'dration of the isolated inhibitor molecules. The latter explanation seems 
plausible as the isolated inhibitor was found to be a sialoglycoprotein containing 
about 13.5% carbohydrate. Because of the glycoproteinic nature of the isolated 
inhibitor the molecular weight obtained by gel filtration (56.4 KDa) was higher 
than the molecular weight obtained by SDS-PAGE (51 KDa). 
The inhibitory activity measurements of buffalo serum aiantitrypsin at 
increasing urea and guanidine hydrochloride concentration show a gradual decrea-
se in the antitryptic activity of the inhibitor with an increase in urea concentration, 
still retaining some of its inhibitory acti\ity (22%) even at 9M urea concentration. 
Alternatively, the inhibitor showed an abrupt decrease in its activity as the concen-
tration of guanidine hydrochloride was increased finally reaching zero at about 5M 
V l l 
guanidine hydrochloride concentration. The results suggested that the inhibitor 
isolated in this thesis has a rigid structure and also that guanidine hydrochloride 
acts as more potent denaturant than urea. 
That the isolated buffalo serum ai antitrypsin is a tryptophan containing 
protein was studied by UV spectroscopy, solvent perturbation difference spectra 
and fluorescence spectroscopy. The UV absorption spectra of the inhibitor in 9M 
urea showed a distinct blue shift as compared to native inhibitor characteristic of 
conformational changes taking place in the buffalo serum ai antitrypsin. Denatu-
ration in 9M urea and consequent exposure of tyrosyl residues was indicated in the 
difference spectrum by the presence of clear cut trough at 286 nm while the abse-
nce of any feature in the 290-292 run range indicated no change in the environ-
ment of tryptophan residues. As observed during activity measurements that the 
inhibitor has a rigid structure and resistant to denaturation even at 9M urea was 
further confmned by the presence of a clear cut trough at 286 imi and also the 
presence of a trough in 290-292mn range in the difference spectra obtained by 
denaturation in 6M guanidine hydrochloride which were also suggestive of the 
exposed nature of both tyrosine and tryptophan residues present in buffalo serum 
tti antitrypsin. 
Solvent perturbation difference spectra obtained by denaturation in 9M 
urea using 20% (v/v) dimethyl sulphoxide indicated about 48% exposure of trypto-
phan residues while the spectra obtained by denaturation in 6M guanidine hydro-
chloride indicated 75% exposure of tryptophan residues in the native buffalo 
serum aiantitrypsin. 
Fluorescence results showed that the native inhibitor had an emission 
maxima of 336 nm using excitation wavelength of 276 nm which indicated the 
presence of tryptophan residues. The tryptophan fluorescence results showed a 
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distinct blue shift of the emission maxima of inhibitor to 335 nm in 9M urea while 
a red shift of the emission maxima of inhibitor to 345 nm in 6M guanidine 
hydrochloride compared to native inhibitor emission maxima of 337 rmi. The red 
shift in emission maxima obtained was indicative of the exposure of tryptophan 
residues to the aqueous environment. That of the two guanidine hydrochloride acts 
as a potent denaturant has also been shown by the fluorescence intensity meas-
urements at varying urea and guanidine hydrochloride concentration. The fluore-
scence intensity was found to decrease and the inhibitor denatured in 6M guani-
dine hydrochloride had the lowest fluorescence intensity. 
Denaturation curve analysis of bufl"alo serum aiantitrypsin at varying con-
centration of urea and guanidine hydrochloride show no change in the fo values 
upto about 2.0M urea and 1.2M guanidine hydrochloride concentration followed 
by a transition which was steep and gradual suggesting noncooperative nature of 
the process of unfolding. The A GD"2° value (3.17 Kcal/ mole) obtained in case of 
urea denatured inhibitor was found to be in excellent agreement with the value of 
A GD^ Z*^  (3.42 Kcal/ mole) obtained in case of guanidine hydrochloride denatured 
inhibitor irrespective of the fact that guanidine hydrochloride acts as more potent 
denaturant than urea. Thus the various denaturation studies (activity profile, UV 
difference spectroscopy, fluorescence measurements) show the relative effective-
ness of these two denaturants on buffalo serum aiantitrypsin and also that the inhi-
bitor has a fairly rigid structure as observed by its capacity to retain some of its 
inhibitory activity even at 9M urea concentration. It was also observed that the 
denaturation of buffalo serum aiantitrypsin in guanidine hydrochloride was comp-
lete at a little more than half the concentration as compared to urea. 
CD spectrum of native buffalo serum aiantitrypsin showed the presence 
of both the a helical and p-pleated sheet structure. While the CD spectrum of the 
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inhibitor denatured in 9M urea show a decrease in negative ellipticity indicating 
some changes in the backbone conformation. The CD spectrum of inhibitor dena-
tured in 6M guanidine hydrochloride shows a fully denatured backbone conforma-
tion. 
The isolated buffalo serum ai antitrypsin was competitive in nature as it 
was found to inhibit trypsin completely at enzyme inhibitor molar ratio of 1:1 and 
the competitive nature was further confirmed by the kinetic parameter (Km and 
Vmax) values determined by double reciprocal plot. 
It can be concluded on the basis of the studies carried out in this thesis 
that 
(i) Buffalo serum ai antitrypsin has been isolated and purified by a very 
simple and gentle procedure. No extremes of pH or temperature, no expo-
sure to solvents distinguish this from previously reported methods. 
(ii) Buffalo serum ai antitrypsin obtained, satisfies many criteria of homogen-
eity as It was found to be homogeneous both with respect to charge 
and size as shown by ion exchange chromatography, PAGE, SDS-PAGE, 
gel chromatography on Sephacryl S-200HR column as well as during 
HPLC gel filtration. 
(iii) The presence of a single band during SDS-PAGE both under reducing and 
non-reducing conditions predict a single chain structure of the native mol-
ecule. 
(iv) Buffalo serum ai antitrypsin was found to contain two free sulphydryl 
groups. 
(v) Buffalo serum ai antitrypsin was observed to be a sialoglycoprotein conta-
ining about 2.6% sialic acid and 10.9% neutral hexose. 
(vi) Buffalo serum ai antitrypsin showed inhibitory specificity different from 
human aiantitrypsin. The former was observed to be a potent inhibitor 
of bovine trypsin and only a moderate inhibitor of elastase while the latter 
has been reported in earlier studies to be a potent inhibitor of elastase. The 
difference in the inhibitory specificities can be due to the differences in 
the amino acid sequence within the reactive site region. 
(vii) Interestingly, it was observed that though the buffalo serum ai antitrypsin 
contains both neutral hexose and sialic acid residues like its human coun-
terpart (reported in earlier studies), it (buffalo serum ai antitrypsin) shows 
inhibitory specificity different from human ai antitrypsin but similar to 
goat tt] PI which has been reported earlier to be a glycoprotein devoid of 
sialic acid residue. Thus it can be said that sialic acid residues have no 
role to play in deciding the inhibitory behaviour of the inhibitor. 
(viii) Molecular weight of buffalo serum ai antitrypsin obtained by gel filtration 
was found to be about 9% higher than the molecular weight obtained by 
SDS-PAGE which can be attributed to the high content of carbohydrate 
residues in the molecule. 
(ix) UV difference spectra of buffalo serum ai antitrypsin obtained with urea 
or guanidine hydrochloride indicate that tryptophan residues were not exp-
osed when denatured in urea but were exposed when guanidine hydrochl-
oride was used. Thus guanidine hydrochloride can be said to be a more 
potent denaturant. 
XI 
(x) Solven perturbation difference spectra indicate that irrespective of the den-
aturant used the tryptophan residues were only partially accessible to the 
solvent. The accessibility increases when guanidine hydrochloride was 
used as a denaturant. 
(xi) Tryptophan fluorescence results confirmed the conclusion derived from 
UV spectrum and solvent perturbation analysis. Denaturation of buffalo 
serum ai antitrypsin in 6M guanidine hydrochloride was observed to lead 
to a large red shift in the emission maxima as well as decrease in fluoresc-
ence intensity which were indicative of major conformational changes in 
the surrounding of the chromophore (exposure of tryptophan residues to 
the aqueous environment in the unfolded state). Similar results were obta-
ined when fluorescence intensity of the inhibitor was monitored at 337imi 
in the presence of varying amount of urea and guanidine hydrochloride. 
(xii) Of substantial interest was the observation that inspite of guanidine hydro-
chloride being a more potent denaturant AGD"2° values obtained both in 
case of urea and guanidine hydrochloride were found to be in excellent 
agreement. It was also observed that denaturation of inhibitor in guanidine 
hydrochloride was complete at a little more than half the concentration as 
compared to urea. 
(xiii) CD spectra of native buffalo serum ai antitrypsin compared with 9M urea 
denatured aiantitrypsin and 6M guanidine hydrochloride denatured ajant-
itrypsin indicate that the native molecule consists of a high content of a-
helical and P-pleated sheet structure while the backbone conformation 
was slightly disorganised in 9M urea further it was also observed that the 
backbone conformation was fully disorganised in 6M guanidine hydrochl-
oride. 
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(xiv) The results obtained during UV spectroscopy, activity measurements (in 
the presence of denaturants), solvent perturbation studies, fluorescence 
measurements, denaturation curve analysis and CD measurements indica-
ted that the buffalo serum ai antitrypsin has a fairly rigid and stable struct-
ure. 
(xv) That the buffalo serum aj antitrypsin acts as a competitive inhibitor has 
been been shown by the stoichiometric analysis of the inhibitor binding to 
trypsin in 1 : 1 ratio as well as from the values of kinetic parameters 
(Km and Vmax) obtained by double reciprocal plot. 
X l l l 
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INTRODUCTION 
INTRODUCTION 
The regulation of proteolytic enzymes in tissues by endogenous inhibitors 
is a critical requirement in the maintenance of homeostasis. These proteins are 
found naturally occurring in blood plasma and account for more than 10% of its 
total content with vast majority targeted towards the serine proteinases known to 
be involved in phagocytosis, coagulation, complement inactivation and fibrinolysis 
(Potempa et al. 1995). There are several classes of proteinase inhibitors (Table I), 
one superfamily referred to as the serpins (serine proteinase inhibitors) predomina-
tes (Carrell & Travis, 1985) with its members also being found in plants and 
viruses (Brandt et al., 1990; Muller and Palumbo, 1991). Some of the major seri-
ne proteinase inhibitors are listed in Table II. 
One of the most abundantly found serpin in blood is naturally occurring 
trypsin inhibitor also known as aiantitrypsin (aiAT). Naturally occurring trypsin 
inhibitor (aiAT) are a class of proteins capable of combining with elastase, trypsin 
and chymotrypsin to form an inactive complex, ai AT combines strongly with elas-
tase, a powerful serine proteinase capable of degrading the major components of 
connective tissue matrix (Travis and Salvesen, 1983; Carrell and Travis, 1985). 
The inhibitor-enz>Tne complexes are almost certainly held together by secondary 
rather than primary bonds. Since one partner in the inactive complex is an active 
enzyme, whereas the second when free, exhibits a measurable enzyme inhibiting 
activity. This system offers a chance for investigating certain aspect of protein-
protein interaction which are less accessible to experimental approach in the case 
of proteins that are not known to have such activities. 
Jacobsen (1955) localized the major trypsin inhibitors in the electrophore-
TABLE I 
Major Proteinase Inhibitors found in Plasma 
Name Abbreviation 
al -AT 
^ Achy 
MW 
55,000 
69,000 
Mean 
Concentration 
(g/l) 
2.0 
0.4 
Class 
Serine 
proteinase 
Serine 
proteinase 
1. a Antitrypsin" 
3. Inter-a-trypsin '^  lal 160,000 0.4 
4. a -Macroglobin "^  a^M 72,500 2.0 Endopepti-
dase 
5. a-Cysteine 
proteinase 
inhibitor^ 
175,000 Cysteine 
proteinase 
MW = Molecular Weight (daltons) 
a. Crawford (1973), Ganrot (1972), Chan et al. (1972), Harpel & Brower (1983) 
b. Schulze el a/.(1962), Harpel & Brower (1983) 
c. Heide et al. (1965), Heimburger et al. (1971) 
d. Jones et al. (1972), Barret & Starkey (1973), Ganrot & Scherster (1967), Harpel 
& Brower (1983) 
e. Travis & Salvesen (1983) 
TABLE II 
Major Serine Proteinase Inhibitors (Serpins) 
Name 
a,antitrypsin" 
Antichymotrypsin'' 
a^ Antiplasmin' 
Antithrombin III'' 
C-1-inhibitoi* 
Kallistatin^ 
Abbreviation 
a,AT 
Achy 
a^AP 
AT III 
C-l-inh 
-
Enzyme inhibited 
Neutrophil elastase 
Cathepsin G 
Plasmin 
Thrombin 
CI esterase 
Kallikrein 
a. Beatty, Bieth & Travis (1980) 
b. Travis & Salvesen (1983), Hooke et al., (1993) 
c. Travis & Salvesen (1983) 
d. Preissner & Jenne (1991) 
e. Travis & Salvesen (1983) 
f. Chaie/a/. (1993) 
tic tt] zone and Bundy and Mehl isolated the inhibitors in 1959. Schulze et al. 
(1955) had isolated 3.5S aj-glycoprotein without observing its capacity to link ser-
ine proteinase which they recognized in 1962 and coined the name apantitrypsin. 
Source 
tti antitrypsin, the principal proteinase inhibitor, is the major component of 
ai globulins and is produced by liver (Momex et al., 1986). The two major sites of 
ttiAT gene expression are hepatocytes and the mononuclear phagocytes (Schultz 
and Heremans, 1966; Perlmutter et al., 1985). 
The hepatocytes contain 200-fold more ajAT mRNA transcripts per cell 
than do mononuclear phagocytes, such as blood monocytes and alveolar macroph-
ages. The ttjAT gene is regulated in certain inflammatory states, pregnancy, use of 
estrogen, progesterone combinations or anabolic steroids (Kueppers,1968; Laurell 
et al., 1967; Aronsen et al., 1972; Eriksson, 1983; Gadek et al., 1980; Wewers et 
al., 1987). 
The path of aiAT biosynthesis is typical of a secretory glycoprotein. The 
a,AT mRNA is translated on ribosomes bound to rough endoplasmic recticulum. 
As the ttiAT polypeptide is synthesized, it proceeds through the membranes of the 
endoplasmic reticulum to its lumen. Within the cistema of rough endoplasmic reti-
culum the three carbohydrate side chains are added as the protein begins to fold 
into its three dimensional configuration. 
The protein is translocated to the golgi apparatus where the side chain 
processing of the oligosaccharides is completed. The complete molecule with com-
plex type of side chain is then secreted. The half hfe of ajAT in blood is about 4-5 
days. Approximately 34 mg of aiAT is produced per day per kilogram of body 
weight (Jones et al., 1978). 
Physicochemical Properties 
Some of the physicochemical properties of aiAT are shown in Table III. 
The molecular weight of aiAT determined by various techniques varies from 
49,500 to 60,000 (Crawford, 1973; Chan et al., 1973; Potempa et al, 1995). The 
molecular weight of 49,500 obtained by sedimentation equilibrium analysis was 
found to be in close agreement to the value obtained by SDS-PAGE i.e., 50, 300 
(Crawford, 1973). 
Amino Acid Composition and Carbohydrate Content 
Two reports on the amino acid composition and number of carbohydrates 
of ai AT present are shown in Table IV . The protein contains a higher number of 
acidic amino acid residues (Aspartic acid and glutamic acid) as compared to basic 
amino acids (His, Lys and Arg). Number of half cystine residues varies from one 
to two ajAT contains a few residues of carbohydrates viz- maimose, galactose and 
sialic acid. 
tt] AT is made up of 394 amino acid residues arranged in a single polypep-
tide chain (Crawford, 1973) with glutamate or glutamine being found at the N-
terminal. Considerable homologies have been found in the N-terminal amino acid 
sequences of goat and sheep aiAT (Potempa et a/., 1995 ; Sinha et al., 1988). 
Structure 
tt] AT is a glycoprotein having about 370-394 amino acids and three oligo-
TABLE III 
Physicochemical Properties of a/iT 
Properties Values Reference 
Molecular weight by 
sedimentation 
equilibrium (daltons) 
49.500 Crawford (1973) 
Molecular weight by 
SDS-PAGE (daltons) 
Molecular weight by 
gel filtration (daltons) 
Partial Specific 
volume 
PI (isoelectric point) 
A '°°27g (extinction Coeflf.) 
S^p W (Sedimentation 
constant) 
D,pW(Cm2sec-l) 
Helical Content (%) 
Pleated sheet (%) 
Overall dimension 
50,300 
54,000 
58,000 
60,000 
0.728 
4.8 
5.3 
3.41 
5.2 
35 
44 
67A''x 32A" X 32A« 
Crawford (1973) 
Chan e/a/. (1973) 
Potempae/a/. (1995) 
Potempae/a/. (1995) 
Crawford (1973) 
Schonenberger (1955) 
Bundy And Mehl (1959) 
Bundy and Mehl (1959) 
Bruch era/. (1988) 
Bruch era/. (1988) 
Lobermaim et al. (1984) 
TABLE IV 
Amino Acid and Carbohydrate Content of Human a^A T 
Residues 
Aspartic Acid 
Threonine 
Serine 
Glutamic Acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
T>Tosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
Half-cystine 
Tr>T3tophan 
Mannose 
Galactose 
Fucose 
N-Acetylglucosamine 
Sialic Acid 
Residues/ 45,000' 
38 
26 
18 
46 
15 
19 
22 
21 
07 
16 
39 
06 
23 
39 
12 
06 
02 
02 
14 
-
1 
10 
26 
Residues/ 50,000'' 
44 
31 
22 
50 
16 
22 
24 
23 
08 
18 
45 
07 
29 
32 
13 
07 
01 
02 
07 
05 
-
10 
06 
a. Heimburger era/(1964, 1971) 
b. Crawford (1973). 
saccharide side chains (Travis and Salvesen, 1983, Carrell and Travis, 1985; 
Carrell, Pemberton and Boswell, 1987) linked with Asn-46, Asn-83 and Asn-247. 
An oligosaccharide chain of aj AT may be biantennary or triantennary, each chain 
containing 2-3 sialic acid, 2-3 galactose, 4-5 N-acetylglucosamine and 3 mannose 
residues, the terminal residues being sialic acid. The carbohydrate moieties reacted 
specifically with concanavalin A - Sepharose due to the presence of internal mann-
ose and N-acetylglucosamine. Carbohydrate moieties are apparently not required 
for its inhibitory activity, since genetically engineered aiAT devoid of carbohyd-
rate had normal inhibitory activity (Travis et ai, 1985; Gadek and Crystal, 1982; 
Lenner, Garrison and Pravda, 1973; Casolaro et al., 1987; Guzdek et al., 1990). 
Carbohydrate side chain of ajAT is probably required for its kinetic stability. 
Spatial structures of native functional serpins have not yet been determin-
ed, however three dimensional analysis of ajAT has been described (Baumann et 
al., 1991; 1992; Loberman el al., 1984; Mourey et al., 1990). h has a highly 
ordered tertiary structure (Huber and Carrell, 1989 ; Carrell and Evans, 1992) with 
the predominant feature of cleaved, inactive serpins being the presence of an anti-
parallel six-stranded (3-sheet (Sheet A) in which the central strand (S4) contains 
several residues up stream from the cleavage site.Those down stream (N...C) are 
located on the surface of the protein within a second P-sheet. Thus the 2 residue of 
the scissile bond are rigidly fixed on opposite poles of the molecules and separated 
by about 70 A . This is in accordance with the fact that cleavage of functional inh-
ibitor must be followed by dramatic transformation of the structure from stressed 
(S), labile conformation to a more ordered heat stable relaxed (R) form. 
The R-S transition , which is totally dependent on the primary structure of 
the hinge region of the RSL (P9 to Pi5) is thought to be a prerequisite for inhibitory 
activity. In this region strand S5 turns to reenter as strand S4 and then leaves the 
sheet A to form part of RSL. Thus P9-P15 is strongly conserved in all inhibitory 
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serpins and mutation within this region results in the loss of inhibitory activity 
(Huber and Carrell, 1989). 
Mechanism of Action 
The mechanism of formation and the structures of serpin-inhibitor com-
plex are not completely understood. It has been proposed from comparison of inh-
ibitor and non-inhibitor serpins in the cleaved and uncleaved forms that insertion 
of strand S4 into the pre-existing P-sheet is a requirement for serpin inhibitor 
activity (Wright and Scarsdale, 1995). 
Proteolysis is the one of the most important biological fimctions involved 
in protein synthesis, in control of protein destination, zymogen activation and in 
control of protein death. Because of the importance of proteolysis it must be con-
trolled and one of the steps in control of proteolysis is the existence of proteinase 
inhibitors. Some of the inhibitors are highly specific and inhibit only a small frac-
tion of proteinases while others show a broad inhibitory spectrum. For the latter 
we talk about two type of enzymes-cognate enzymes i.e., enzymes which recog-
nized the inhibitor's reactive site and combine with it to form the inactive enzyme 
inhibitor complex and the other one is the target enzyme - enzymes that the inhi-
bitor has the evolved to control (Laskowski, 1986). 
The exact mechanism by which aiAT inactivates its target enzyme e.g., 
elastase is also not fiilly understood, it is believed that the inhibitor acts as a trap 
for the target enzyme by offering its reactive site peptide bond as a good substrate 
(Travis and Salvesen, 1983; Carrell and Travis , 1985). Elastase readily attacks the 
reactive site peptide bond between Met-358 and Ser-359 in ai AT and forms a 
tightly bound complex according to the equation : 
11 
E + I= C 
koff 
where E is the en2yme, I is the inhibitor and C is the enzyme inhibitor complex. 
The complex is stabilized by polar and hydrophobic interaction and midergoes 
very slow dissociation to give active enzyme and inactive cleaved inhibitor (Travis 
and Salvesen, 1983; Carrell and Travis, 1985; Carrell, Pemberton and Boswell, 
1987) according to the equation : 
E + I = C = E + I* 
*o£f '^ on 
where I* stand for inactive cleaved inhibitor. The complex is removed from circu-
lation and catabolized in liver and spleen. Met-358 which defines the inhibitory 
specificity of ai AT constitute the reactive centre and acts as a bait for the serine 
proteinase. The reactive site of the inhibitor is situated near its C-terminal (Carrell, 
Jeppson and Laurell, 1982). It does not contain any disulfide bond and the lone 
Cys-232 may be blocked with cysteine and glutathione. However the thiol group 
remains in the reduced form in the native inhibitor and serves as a scavenger for 
oxidants. 
That the inhibitor traps target enzymes by serving as an ideal substrate and 
active centre Met-358 acts as a bait for the enzyme is supported by the structural 
studies of Lobermann et al., 1984. The active centre Met-358 presumably occurs 
in the exposed loop comprising of 12 residues (Ala-348 to Ser-359) and therefore 
it serves as a good substrate. In the nicked ajAT Met-358 is separated from Ser-
359 by a distance of 69A° ( Fig. 1.). This would mean that in the native ajAT the 
sequence Ala-348 to Ser-359 must be plucked out from (3-sheet to form a strained 
loop so that the native aiAT is likely to exist in a strained (S) conformation 
representing a metastable state thereby explaining the difficulty in cfyst^lizing the 
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native inhibitor. However, upon cleavage of Met358-Ser359 bond the strain is 
released and the nicked inhibitor acquires the more stable and relaxed (R) conf-
ormation. Accordingly the nicked inhibitor is readily crystalized (Lobermann et 
al., 1984) The conversion of S to R is accompanied by the major conformational 
changes has been indicated by the several lines of evidence. First, while the nicked 
inhibitor remained in solution after heating at 80°C for two hours, the native ai AT 
precipitated upon incubation even at 60V (Carrell and Owen, 1985). Second, 
circular dichroism spectra of intact and nicked aiAT were found to differ subs-
tantially both in near and far ultraviolet region (Bruch,Viess and Engel, 1988). 
Fluorescence spectrum measurement shows appreciably higher tryptophan quan-
tum yield in the nicked inhibitor as compared to intact inhibitor suggesting more 
exposure of tryptophan residues. Additionally proteolytic modification of the aj. 
AT resulted in the expo- sure of new antigenic determinant unavailable to the nati-
ve inhibitor (Agostini el ai, 1985; Zhu and Chan, 1987). 
Considerable sequence homology has been revealed between different me-
mbers of serpin superfamily (Carrell, Pemberton and Boswell, 1987; Hunt and 
Dayhoff, 1980). Some of the inhibitors belonging to serpin superfamily along with 
their reactive centre are listed in Table V. 
The mechanism of inhibition is consistent with the formation of stable 
proteinase-inhibitor complexes whose formation and stability are kinetically and 
thermodynamically controlled. The sequences of strands S3 A, S4A and S5A mod-
ulate inhibitor formation and alters the balance of substrate and inhibitor complex 
products of the reaction (Wright and Scarsdale, 1995). In vivo inhibitor-proteinase 
complexes, and to a lesser extent cleaved inhibitors are taken up by specific hepa-
tocyte receptors (Audenaert et al., 1994; Theunissen et al., 1993; Lomas et al., 
1993; Bernstein et al.,1977, Gonias et al., 1982; Fuchs, Schifinan and Pizzo, 1982; 
Fuchs, Michalopoulos and Pizzo, 1984; Pizzo,Mast, Feldmann and Salvesen, 
14 
TABLE V 
Reactive Centres in Serpin Superfamily 
Serpins Target enzyme Reactive centre residues 
P P P ' P* P• P ' 
2 1 1 2 3 4 
a, Antitrypsin Elastase Pro Met Ser He Pro Pro 
Inter a, Antitrypsin Elastase Pro Val Ser He Pro Pro 
Antithrombin HI Thrombin Gly Arg Ser Leu Asn Pro 
Antichymotrypsin Chymase Leu Leu Ser Ala Leu Val 
Table from Travis and Salvesen (1983). 
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1988; Pizzo, 1989; Perlmutter et al., 1990a ; Perlmutter et ai, 1990b). There are 
also high concentrations of uncomplexed cleaved strand inserted inhibitors in plas-
ma, which arise from slow deacylation of the proteinase from inhibitor (Wright 
and Scarsdale, 1995). Complete removal of inhibitor proteinase complex with fee-
dback stimulation of inhibitor synthesis (Perlmutter et a/., 1990b) could deplete 
proteinase concentrations beyond that required for primary biological response. 
Formation of inhibitor proteinase complexes followed by slow modulated deacy-
lation to free active proteinase and cleaved inactive inhibitor provides a mecha-
nism for transient pulsed decrease of proteinase activity followed by gradual resto-
lation without rapid replenishment of the inhibitor pool. The rates of complex bre-
akdown depend upon its structure, would thus govern the short term level of prot-
einase activity (Wright and Scarsdale, 1995). 
Regulation of Inhibitory Activity 
The amino acid in the Pi-position appears to dictate inhibitor specificity. 
In the case of aiAT this residue is Met and it has been shown that oxidation of this 
inhibitor converts the Pi amino acid to Met-SO (Travis and Salvesen, 1983). 
Concomitant with this reaction is a dramatic loss of functional activity, and it is 
now believed that in vivo, this may be a mechanism to regulate elastase inhibitory 
activity at inflammatory sites. This event would be spatially limited by short radius 
of diffusion of phagocyte derived oxidizing agents into tissue and probably facili-
tates local inflammatory processes, including uncontrolled degradation of connec-
tive tissue proteins. 
Control of proteolytic activity by serpins is reasonably well understood. 
Major mechanism for regulating the inhibitory activity involves cleavage of RSL 
by non-target proteinases to produce an inactive inhibitor. Several, bacterial, ftm-
gal and non mammalian proteinases have been shown to inactivate specific inhi-
bitors (Kress, 1986; Potempa, Watorek and Travis, 1986) and therefore augment 
16 
uncontrolled proteolysis in tissues, many mammalian enzymes derived fibroblasts 
or neutrophils have also been found to perform this function (Desrochers, Jefferey 
and Wass, 1991; Mast et ai, 1991; Potempa, Fedak, Dubin and Travis, 1991) sug-
gesting that degradation of proteinase activity can be accomplished as part of no-
rmal or abnormal processes within tissues. 
aiAT in tissues is rapidly inactivated by Pseudomonas aeruginosa elas-
tase (Morihara et a!., 1984) a pathway that is believed to result in the loss of fun-
ctional neutrophil elastase inhibitor>' activity in individuals infected with this orga-
nism. If aiAT becomes inactivated the active elastase may now attack the reactive 
site of aianti-chymotrypsin and rapidly converts it into inactive inhibitor (Potempa 
et al., 1991) thus reducing control of Cathepsin G. In this manner two major neut-
rophil proteinases may exist in a high concentration of proteolytically inactivated 
serpins. The result being uncontrolled proteolysis and tissue damage (e.g., emphy-
sema, periodontitis etc.). 
Genetic Variants of aiantitrypsin 
The ai AT gene compnsing of seven exons and six introns over 12.2 Kb of 
chromosome 14 (Long Chaudra, Woo, Davie and Kwachi,1984; Rabin,Watson, 
ICidd. Woo, Berg and Ruddle, 1986; Shien et a/, 1987) is highly pleomorphic and 
as many as 75 alleles of the inhibitors have been identified. Besides normal aiAT 
alleles there are deficient alleles that are associated with low serum levels of the 
inhibitor. The deficient alleles Z, S and M procida have been snidied more exten-
sively (Travis and Salvesen, 1983; Carrell and Travis, 1985; Carrell, Pemberton 
and Boswell, 1987;Curiel et a/.,1989;Takahashi et al.J9SS). In Z type aiAT Glu-
342 which forms salt bridge with Lys-290 in normal inhibitor is replaced by Val. 
The Z-mutation results in exaggerated intracellular accumulation of newly synth-
sized inhibitor (Brantly, Courtney and Cr>stal, 1989) and hence in the reduced 
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secretion of a, AT. The mechanism of aggregation of Z type ai AT is unclear. For-
mation of salt bridge between Glu-342 and Lys-290 is crucial for correct and rapid 
protein folding so that the folding of Z-variant is not only slow but is unable to 
bury hydrophobic amino acid residues and the exposure of these residues to 
predominantly acqeous intracellular environment is likely to result in aggregation 
(Lobermanne/o/., 1984). 
The S-type gene differs from the normal aiAT gene by the single base 
(GAA in normal - GTA in S- type gene) causing substitution of Glu- 264 by Val. 
The S-type aiAT had the same serum half life (Jeppson et al. 1978) and nearly 
same association rate constant (Ogushi et al. 1988) for neutrophil elastase as nor-
mal ttjAT in S alleles has been shown to arise from excessive intracellular degr-
adation of newly synthesized inhibitors which in turn leads to reduced secretion. 
Reduced stability of the conformation of S-variant may account for its exaggerat-
ed degradation. Salt bridge formation between Glu-264 and Lys-383 (Lobermann 
et al., 1984) does not occur in S-variant destabilising the conformations of the 
mutant inhibitor . Proteins with perturbed conformations are more susceptible to 
intracellular proteolysis (Wilson and Hatfield, 1984; Lloyd and Olsen , 1987). In 
M procida alleles substitution of Leu-41 by Pro disrupts a-helix resulting in struc-
tural perturbation consequently the mutant inhibitor is degraded intracellularly 
prior to secretion (Takahashi et al., 1988). 
Denaturation 
The structural integrity and stability of 3D structure of globular proteins 
are maintained by numerous non-covalent interactions, including H-bond, Van der 
waals and hydrophilic interaction (Privalov, 1989; Dill, 1990) Native conformati-
on of intact aj AT is disrupted by exposure to extremes of pH, temperatures and 
denaturants. The latter include urea and its derivatives, guanidine hydrochloride, 
SDS and organic solvents such as 2-Chloroethanol dioxane and propylalcohol. 
18 
Thermodynamic stability effects on serpins has also been studied ( Izabela and 
Otlewski, 1996). Proteolytically modified serpins are supposed to be more stable 
than intact serpins (Izabela and Otlewski, 1996; Bruch, Weiss and Engel, 1988). 
Inhibitor structure can be divided into two parts. The solvent exposed pro-
teinase binding loop and the scaffolding, which forms the core of the inhibitor and 
maintains the loop in canonical conformation (Bode and Huber, 1992). Both seg-
ments are cooperatively linked and the inhibitor denatures according to the two 
state mechanism (Moses and Hinz, 1983; Otlewski and Laskowski, 1985; Jackson 
et al., 1993; Jackson and Fersht, 1994). In the loop, the unique peptide bond, 
called the reactive site can be specifically hydrolyzed with cognate proteinase. pH-
independent hydrolysis constant for cleavage of this peptide bond was often found 
to be around unity (Ardelt and Laskowski, 1991) implying that Gibbs energy of 
native inhibitor before and after cleavage reaction are equal. However stabilities of 
both forms are not equal (Otlewski and Laskowski, 1985). 
Biological Functions 
aiAT belong to a class of inhibitors called serpins. It inhibits trypsin, chy-
motrypsin, thrombin and plasmin, it really acts on neutrophil elastase a powerftil 
serine proteinase capable of degrading the major components of connective tissue 
matrix (Travis and Salvesen, 1983; Bieth, 1986). When serum levels of ajAT are 
below 35% of the normal the inhibitor concentration becomes insufficient to prot-
ect the lower respiratory tract from its burden of neutrophil elastase placing such 
individuals at a high risk for development of pulmonary emphysema. 
Plasma/ serum proteins were shown to be altered in patients with alcohol 
related disease. Abnormal microheterogeneity of haptaglobin and aiAntitrypsin 
(Gravel et al., 1996) was detected in serum of all alcoholic patients. 
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tti AT is synthesized by in vitro cultures of hepatocytes (Gitlin and Bias-
ucci,1969). In some diseased conditions (Sharp, 1971) were observed a large nu-
mber of inclusion bodies in the endoplasmic reticulum of hepatocytes. These glo-
bules reacted strongly with antibodies to aiAT. It was suggested that the globule 
consists of ttjAT synthesized and retained within the endoplasmic reticulum. The 
doubling of aiAT level in plasma during administration of estrogens for therape-
utic or contraceptive purposes may be attributed to a synthesis enhancing effect of 
estrogens (Fagerhol and Laurell, 1970). Increased synthesis also leads to raised 
plasma level of aiAT during most inflammatory reactions. Normal mean plasma 
level of ajAT is estimated to be 2.0 -2.2 g/1 (Kueppers, 1967; Ganrot, 1972) in 
adults and in full term newborn while the concentration is lower in premature 
births and often markedly lower in the respiratory distress syndrome (Kotas et al, 
1972; Mathis et al.,1973). Increased aiAT plasma concentrations is a characteri-
stic finding in acute hepatitis and in acute liver cirrhosis which are not accompan-
ied by increased synthesis of other acute phase reactants (Kindmark and Laurell, 
1972). One of the major functions attributed to aiAT is inactivation of protease 
released mainly intracellularly during activity of granulocytes. It forms fmn comp-
lexes in the protection against pancreatic and bacterial enzymes ajAT also ftmc-
tions as an inhibitor of acrosomal sperm proteinase (Schumacher, 1971). 
One of the major diseases caused by the deficiency of aiAT is emphyse-
ma which is a pathological condition of lung characterised by abnormal perma-
nent enlargement of the alveoli distal to the terminal bronchioles accompanied by 
destruction of their walls and without obvious fibrosis (Snider e( al., 1985). aiAT 
deficiency occurs in individuals who inherit the Z allele rather than the normal M 
allele. In Z allele lysine has been substituted for glutamic acid at amino acid posi-
tion 342, glycosylation is thought to be abnormal and secretion of the protein froiji^ 
hepatocytes is severely reduced in homozygotes, resulting in circulatory levels that 
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are less than 20% of the normal. Since ajAT is the major serum inhibitor of neut-
rophil elastase and in aiAT deficient individuals the elevated neutro|Ail elastase 
levels is thought to be one of the essential factors for development of puhnonary 
emphysema (Tetley, 1992; Carrell, Jeppson and Laurell et al., 1982). 
The alveolar structure which is destroyed in emphysema is the connective 
tissue matrix (Gadek et al., 1980). This matrix is composed of four classes of 
macromolecules, collagen, elastic fibres proteoglycans and fibronectins ( Rennard 
et.al.,19S2). For the destructive lung diseases to occur the destruction of elastic 
fibres is of primary importance. Elastin is a unique matrix component because 
only one proteinase elastase is capable of destroying it (Bieth, 1978). Neutrophil 
elastase is a serine proteinase (MW 33000) synthesized within leucocytes. Becau-
se of the formation of high affinity covalent bond between aiAT and neutrophil 
elastase the formers forms a very effective defense of the lung structure against 
attack by elastase. 
Cigarette smoking contributes to the disruption of the fragile structures of 
the lower respiratory tract. Smoking results in increase in the leucocytes concen-
tration and hence in increased exposure of lung tissues to neutrophil elastase. Cig-
arette smoke contains oxidants (Travis and Salvesen, 1983) which modify active 
centre methionine of aj antitrypsin to methionine sulfoxide. The latter is too bulky 
to be accommodated into elastase pocket and therefore oxidative modification of 
the inhibitor abolishes its inhibitory activity .Val mutant of ajAT is an inhibitor 
that has been synthesized by recombinant technique and has been successfully 
tested (George et al., 1984) as an inhibitor of connective tissue breakdown in a 
model of inflammation. It holds promise for intravenous replacement therapy in 
patients with severe ajAT deficiency . 
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Another disease associated with the aiAT deficiency is bronchiectasis 
which is a state described when one or more bronchi are abnormally or perman-
ently dilated. Deficiency of ai AT make the bronchi more susceptible to damage 
by elastase, secreted by bacteria and neutrophils following lung infection. Patients 
suffering from bronchiectasis have low levels of ajAT (Varpela et A/., 1978, Kagan 
et ai, 1975; Jones et a/., 1985 ) leading to recurrent bronchiopulmonary infections, 
bronchiectasis and severe complications of ottitis media (Carlsson, 1983). 
Severe aiAT deficiency is also associated with neonatal hepatitis, crypto-
genic cirrhosis in children and adults, non-B chronic active hepatitis (Sharp et ai, 
1969; Hodges et al, 1981; Sveger, 1976; Yunis et ai, 1976). Liver abnormalities 
are believed to occur (1) accumulation of aiAT in the cytoplasm of hepatocytes. 
The accumulated aiAT damages the hepatocytes by its bulk or by some toxic effe-
cts (Sharp, 1982). (2) Lack of sufficient aiAT in the systemic and portal circula-
tion surrounding the hepatocytes (Sharp, 1982). ajAT deficiency is also reported 
to cause certain haemorrhagic disorders in infants such as platelet dysfimction, 
disseminated intravascular coagulopathy and clotting system disturbances (Carrell 
etai, 1980). 
Myoepithelial tumors are intriguing low grade neoplasms that exhibit the 
property of accumulating an abundant extracellular matrix. The accumulation of 
extracellular matrix represents an important exception to the rule of matrix degra-
dation otherwise exhibited by majority of human neoplasms (Stemlicht et ai, 
1996). In addition to structural proteins the myoepithelial cells secreted relatively 
large amounts of proteinase inhibitors especially aiAT (Stemlicht et ai, 1996). 
Abnormal microheterogeniety of a i AT was detected in serum of all alcoholic 
pateints (Gravel et ai, 1996). It was also found that mice lacking hepatocyte 
nuclear factor 1 fail to thrive and die around weaning after a progressive wasting 
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syndrome with a marked liver enlargement. Of the various abnormalities detected 
was the reduced transcription rate of genes like albumin and aiAT (Pontoglio et 
a/., 1996). 
EXPERIMENTAL 
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EXPERIMENTAL 
MATERIALS 
Proteins and Enzymes 
Bovine serum albumin was purchased from Sisco Research Laboratories, 
India. Ovalbumin, a-chymotrypsinogen A, trypsin, cytochrome c and chymotry-
psin were the products of Sigma Chemical Company, USA. Porcine pancreatic 
elastase and casein were purchased from Boehringer Mannheim, Germany. 
Column Chromatographic Media 
Sephacryl S-200 HR and blue dextran-2000 were obtained from Sigma 
Chemical Company, USA. DEAE-Sephacel with a bead size of 40-160 ji having a 
capacit>' of 100-140 eqv. per ml of gel volume was also obtained from Sigma 
Chemical Company, USA. 
Reagents for Electrophoresis 
Dimethyldichlorosilane and coomassie brilliant blue G-250 were purch-
ased from Sigma Chemical Company, USA. Bromophenol blue and N, N, N', N' 
Tetramethylethylenediamine were obtained from P.P.H. Poland and B.D.H. 
England respectively. Acrylamide, N, N'-methylenebisacrylamide, ammonium 
persulphate, Tris, Glycerol, sucrose, glycine, acetic acid ,chloroform and methanol 
were the products of Qualigen Fine Chemicals, India. 
Other Reagents 
a-Benzoyl-arginine-p-nitroanilide hydrochloride and guanidine hydrochl-
oride were purchased from Sigma Chemical Company, USA. Sodium acetate was 
obtained from B.D.H., India. Sodium azide was purchased from Loba Chemei, 
India. Sodium chloride, sodium hydroxide, urea and potassium tartarate were obta-
ined from Qualigen Fine chemicals, India. .Analytical grade samples of glacial ace-
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tic acid, phenol, sulphuric acid, hydrochloric acid, orthophosphoric acid, sodium 
phosphate monobasic and dibasic, copper sulphate, potassium permanganate, 
methanol and liquid bromine were used. 
Miscellaneous 
Dialysis sacs of different flat widths i.e. 25 mm and 43 mm were purch-
ased from Sigma Chemical Company, USA. Millipore filters of pore size 0.45 n 
and 13 mm diameters were the products of Millipore product Division Bedford, 
USA. Solid glass beads were obtained from Kimble Resistant Glass, USA. Stan-
dard buffer Tablets of pH 4.0, 7.0 and 9.2 were purchased from Glaxo, India. 
Glass distilled water was used throughout this study. 
Serum was extracted from fresh buffalo blood obtained from slaughter 
house. 
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METHODS 
pH Measurements 
Measurements of pH were carried out on ELICO pH meter, model Ll-
lOT, using ppC ELICO combined glass electrode type CL-51. Before pH measu-
rements the pH meter was routinely calibrated by standard buffer of pH 4.0, pH 
7.0 and pH 9.2 for measuring the pH value in acidic, neutral and alkaline pH range 
respectively. 
Optical Measurements 
A Shimadzu double beam spectrophotometer, model UV-150-02 was used 
for light absorption measurements in the ultraviolet as well as in the visible region. 
Fluorescence measurements were performed on a Shimadzu Spectrofluorophoto-
meter RF-540 equipped with a data recorder model DR-3 using quartz cell of 1 cm 
path length. 
Determination of Protein Concentration 
(a) Method ofLowry et ah (1951) 
In this method of protein estimation two reagents used were Folin-phenol 
and copper sulphate. 
Preparation of Folin-phenol: This reagent was prepared according to the 
method recommended by Folin and Cicalteau (1972). Two a two litre round botto-
med flask wrapped with a black paper were added 200g of sodium tungstate, 50g 
of sodium molybdate, 44 ml of orthophosphoric acid (90.5%), 200 ml of 11.4 N 
HCl and 1400 ml of water. The mixture was refluxed for about 10 hours. This was 
followed by addition of 300g of lithium sulphate, 100 ml of water and a few drops 
of liquid bromine. The mixture was heated without condenser for 30 minutes to 
remove excess bromine. After cooling tota\ volume was made upto 2 litre with 
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water. The stock solution was filtered and stored in an amber coloured bottle. The 
reagent was diluted four times with distilled water before use. 
Preparation of copper sulphate (copper reagent) : The stock solutions of 
4% (w/v) sodium carbonate, 4% (w/v) sodium potassium tartarate and 2% (w/v) 
copper sulphate were prepared. These solutions were mixed in the ratio of 100: 1: 
1 respectively. The reagent was prepared fresh and filtered before used. 
Procedure : An appropriate volume of protein solution in the range of 0.1-
1.0 ml was taken in a test tube and total volume was made 1 ml by adding distilled 
water or an appropriate buffer. Then 5 ml of freshly prepared copper reagent was 
added and mixed well. After 10 minutes, 1 ml of Folin-phenol reagent was added 
and the contents were mixed thoroughly. Colour intensity was recorded after 30 
minutes at 700 nm against a blank prepared in the same way except that the 
protein was replaced by water or buffer. 
(b) Spectrophotometric method: 
The absorbance of protein solution at 279 run was recorded against a sui-
table blank. The protein concentration was calculated from the absorbance value at 
279 nm using their specific extinction coefficient (E'^ 'icm) at that wavelength. 
Ammonium Sulphate Fractionation 
Fresh blood obtained from the slaughter house was centrifiiged at 10,000 
rpm for 30 minutes to extract serum. Serum thus isolated was further saturated 
with varying amounts of ammonium sulphate. 
Procedure: To 300ml of serum obtained after centrifiigation was added 
52.8g of solid ammonium sulphate with gentle stirring to give 30% saturation. So-
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lution was allowed to stand overnight at 4 '^C. Then it was centrifuged at 5000 rpm 
for 15 minutes. The supernatant and precipitate were tested for antitryptic activity. 
Precipitate having negligible antitryptic activity was discarded. 
To the remaining supernatant (270 ml) was added 33.02g of ammonium 
sulphate to give 50% saturation. The solution was again left overnight at 4 C and 
then centrifuged at 5000rpm for 15 minutes. Again supernatant and precipitate 
were tested for their antitryptic activit>'. Precipitate was again discarded as it sho-
wed negligible antitryptic activity. 
To the remaining supernatant (210 ml) was added 44.94g of solid ammo-
nium sulphate to give 80% saturation. The solution was again left overnight at 4°C 
and then centrifuged at 5000rpm for 15 mmutes. Precipitate obtained showed max-
imum antitryptic activity. Hence the precipitate was collected and dissolved in a 
minimum amount of 0.2M Tris-HCl buffer pH 8.2 containing 0.02M CaCl2 and 
then extensively dialyzed against the same buffer to remove ammonium sulphate. 
Measurement of Trypsin Inhibitory Activity 
Tr>T3sin was allowed to react with BAPNA resulting in the formation of p-
nitroanilide which has intense yellow colour at 410 nm. The intensity of colour 
was used for checking the activity of trypsin in the presence and absence of serum. 
Procedure : Trypsin solution was prepared in 0.00IN HCl. The concentr-
ation of tripsin was determined spectrophotometrically using an extinction coeffi-
cient (E'°°icm) of 15.4 at 279 nm. 43.5 mg of BAPNA were dissolved in 1 ml of 
DMSO. The final volume was made upto 100 ml with 0.2M Tris-HCl buffer, pH 
8.2 containing 0.02M CaC^. 0.1 ml of trypsin was taken in tree tubes marked as C 
for control, S for standard and T for test respectively. In tube C after addition of 
buffer the enzyme was inactivated by adding 1 ml of 30% acetic acid before add-
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ing substrate ( BAPNA) whereas in tube T the enzyme was incubated with serum 
for half an hour at room temperature. The volume of S and T tubes was made upto 
2.5 ml whereas the volume of C was made upto 3.5 ml with 0.2 N Tris-HCl buffer 
pH 8.2. A constant volume of BAPNA (0.5 ml) was added in all the tubes (T) and 
tube S. C, S and T tubes were incubated for 45 minutes at 37°C. The reaction in S 
and T tubes were terminated by adding 1 ml of 30% acetic acid. 
Calculations : The trypsin inhibitory activity of serum was calculated as 
follows using the methods of Erlanger et al. (1961) and Waheed and Salahuddin 
(1975). Suppose the reading of these tubes taken are 
Control- C 
Standard- S 
Test -T 
Then, 
Actual absorbance of standard = (Absorbance of standard - Absorbance of 
control) 
= S-C 
Actual absorbance of test = (Absorbance of test - Absorbance of control) 
- T-C 
Actual absorbance Specific Activity 
Enzyme concentration 
S -C Hence, units of specific activity is 100% activity of 
Enzyme concentration 
trypsin on substrate. 
Percentage inhibition of trypsin is 
Specific acti\ity of test 
100- 100 X 
Specific activity of standard 
1 0 0 - 1 0 0 x ^ ^ % 
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S -T 
= 100 X „ „ % in X ml of appropriately diluted serum. 
Column Chromatography 
(a) Ion exchange chromatography : 
DEAE-Sephacel obtained from Sigma Chemical Company was used as a 
media for ion exchange chromatography. Preswollen DEAE-Sephacel suspension 
in 20% ethanol was suspended in distilled water and fine particles were removed 
by repeated decantation. Before packing a short and broad glass column ( 20 x 
2.5cm) was thoroughly washed with detergent, chromic acid and finally with disti-
lled water. The column was then mounted in a vertical and vibration free manner. 
The narrow bore outlet of the column was connected to a small latex tubing 
attached with a screw stop-cock for regulation of flow rate. A small amount of 
glass wool previously boiled in water was placed at the bottom of the column and 
its surface covered with glass beads. The gel slurry was poured into the column 
with the help of a glass rod to avoid bubble formation. The gel was left to settle 
under gravity overnight at room temperature. The gel bed was stabilized by passi-
ng several bed volumes of 0.03M sodium phosphate buffer pH 6.8, Is = 0.042 
having the same pH and ionic strength as that of the sample. Before the sample 
application the column has to be regenerated. The column was first equilibrated 
with IM sodium acetate pH 3.0 till the pH of the column matches that of sodium 
acetate. Then the column was equilibrated with 0.5M sodium hydroxide in the 
same manner. The column was then closed and left overnight. Then again it was 
equilibrated v t^h IM sodium acetate. Finally the column was equilibrated with 
0.03M sodium phosphate buffer pH 6.8, Is=0.042 till the pH of the column matc-
hed that of the sample to be appbed.The sample was extensively dialyzed against 
0.03M sodium phosphate buffer pH 6.8, Is=0.042. During sample application the 
column bed was drained of the buffer and the sample was then applied. The unbo-
und sample was eluted with 0.03m sodium phosphate buffer pH 6.8, Is=0.042 and 
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then in a batchwise manner using buffer of different ionic strengths (Is=0.042, 
0.1,0.2,0.5,1.0). Fraction of 2-3 ml were collected and monitored by the method 
ofLowry era/. (1951). 
(b) Gel filtration : 
Preswollen Sephacryl S-200HR was suspended in one litre of distilled wa-
ter. As recommended by Pharmacia, the complete swelling was achieved by keep-
ing the gel in a boiling water bath for five hours. After complete swelling. The fme 
particles of the gel were removed by decantation. This process was repeated seve-
ral times till the gel was free from fmes. Before packing a glass column (63 x 1.61 
cm) was thoroughly washed with detergent, chromic acid and fmally with water. 
Then it was mounted in a vertical, sturdy and vibration free position. The narrow 
bore outlet of the column was connected to a small latex tubing attached with a 
screw stop cock for regulation of the flow rate. The radius of the column was dete-
rmined at three different places of the column. Volumes of water corresponding to 
3 cm height in the column were collected in three preweighed bottles. The volume 
of the water (V) corresponding to the height (h) of 3 cm was then determined by 
dividing the weight (w) of water by its density (d) at the particular temperature the 
radius of the column (r) was calculated as follows. 
V = 7ir^h (1) 
7t r ^ h = w/d 
r = V w/d 71 h (2) 
The total volume of the column was calculated by the following equation 
V, = 71 r ^ h (3) 
where h denotes the total bed height of the colunm. 
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A small amount of glass wool previously boiled in water was placed at the 
bottom of the column and its surface was covered with a layer of glass beads. One 
third volume of the column was filled with the operating buffer. Then the gel slu-
rry was slowly poured into the column with the help of a glass rod. The gel was 
left to settle under gravity overnight at room temperature. When the gel formed a 
smooth surface the column was operated with a flow rate of 5 ml per hour. As the 
gel settled down the flow rate was gradually increased to a value higher than that 
to be employed during operation. The gel bed was stabilized by passing three bed 
volumes of sodium phosphate buffer, pH 7.0, Is = 0.15 containing 0.02% sodium 
azide. 
During the sample application the eluent above the column bed was drai-
ned off and then the sample was applied to the column. The stopcock was then op-
ened slowly and the sample was allowed to pass down the upper surface of the gel. 
When all the protein sample had passed into the gel the eluent buffer was applied 
and the elution was performed with a flow rate of 25ml per hour. Fractions 2-5 ml 
were collected which were monitored by the method of Lowry et al. (1951). 
The homogeneity of packing of the column was checked by passing a 
band of 0.2% solution of blue dextran-2000 through the column. The elution volu-
me (Ve) of the blue dextran yielded void volume (Vo) of the column. The internal 
volume (V,) of the column bed was obtained by subtraction of the void volume 
from elution volume of glucose (Andrews, 1970). 
Sephacryl S-200HR column was calibrated by elution of marker proteins 
of known hydrodynamic properties. The void volume of the column was frequen-
tly checked during calibration. 
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Polyacrylamide Gel Electrophoresis 
Polyacrylamide gel electrophoresis was carried out in Tris glycine buffer 
pH 8.2 according to the method of Davis (1964). 
The gel plates were washed with detergent chromic acid and fmally with 
water. The plates were dried, siliconised and any sticky material was removed by 
cotton. Three plastic spacers were placed along the sides and bottom of the plates. 
The plates were mounted in a vertical fashion. The sides of the plates were sealed 
with 1% agarose solution. Three fourth of the space between the plates was filled 
with small pore solution containing 30% (w/v) acrylamide, 0.8% (w/v) N,N' meth-
ylenebisacrylamide, 1.5% (w/v) ammonium persulphate and 0.025% (v/v) N, N, 
N', N' tetramethylethylenediamide (TEMED). The solution was allowed to poly-
merize for 30 minutes at room temperature. Remaining space above the small pore 
solution between the plates was filled with large pore solution. Then a comb was 
inserted between the plates. After the large pore solution polymerizes the comb, 
plastic spacer at the bottom and the bottom bracket are removed. Lower tank of the 
electrophoretic apparatus was filled with buffer. Samples were applied in different 
wells and electrophoresis was carried out by applying a constant current of 2-4 mA 
per well till the bromophenol blue front migrated to nearly 3/4 of the total length 
of the gel The gel was taken out from between the plates and stained 0.1% (w/v) 
coomassie brilliant blue G-250. 
Destaining was performed firstly with 30% (v/v) methanol and 10% (v/v) 
glacial acetic acid and subsequent washes were given with 7% (v/v) glacial acetic 
acid. 
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Determination of Molecular Weight by Sodium Dodecyl Sulphate Poly-
acrylamide Gel Electrophoresis (SDS-PAGE) : 
The molecular weight of the inhibitor was determined by SDS polyacry-
lamide gel electrophoresis in 10% polyacrylamide gel. Electrophoresis was carried 
out according to the method of Laemelli (1970) in Tris glycine buffer pH 8.3 
containing 0.1% SDS. Three fourth of the space between the plates was filled with 
small pore gel solution containing 30% (w/v) acrylamide, 0.8% (w/v) N,N methy-
lenebisacrylamide, 1.5% (w/v) ammonium persulphate, 0.025% (v/\) N, N, N', N' 
tetramethylethylenediamide (TEMED) and 0.1% SDS. After polymerization the 
small pore gel solution was overlaid with large pore gel solution and a comb was 
inserted between the plates. After removal of the comb, sample was applied in the 
wells and electrophoresis was carried out at a constant current of 2-4 mA per well. 
Staining and destaining procedure were the same as that for native polyacrylamide 
gel electrophoresis. 
Ultraviolet Spectral Measurements 
The ultraviolet absorption and difference spectra of purified a i antitrypsin 
was recorded in sodium phosphate buffer pH 7.0, Is = 0.15 at room temperature in 
the wavelength range from 240 nm- 360 nm. The scattering corrections were made 
by extras olation of absorbance values in the wavelength range 350 nm- 330 nm to 
the absorbing region. The inhibitor concentration was 1.7 mg/ ml. 
Fluorescence Measurements 
The fluorescence excitation and emission spectra of pure inhibitors were 
obtained in sodium phosphate buffer pH 7.0, Is = 0.15 at room temperature. 
Generally low protein concentrations were used to minimize inner filter effects. 
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Determination of Extinction Coefficient 
The inhibitor (aiAT) solution was dialyzed extensively against 10 mM 
sodium phosphate buffer pH 7.0, Is = 0.15. Measured volumes of the dialyzed 
protein solutions and last dialysate were taken in pre weighed bottles and their 
weights were recorded. Each of the protein solution and dialysate were taken in at 
least three sets to minimize the percentage error while determining the concentra-
tion of the protein solution. The solutions were kept for drying in hot air oven at 
105°C till the weights were constant. The concentration of the protein solution was 
obtained by difference. Absorbance at 280 nm was recorded for protein solution 
using varying concentration ranging 0.4 mg/ml -2.0 mg/ml. The value of extinction 
coefficient was determined from the slope of the plot between protein concentra-
tion (g/ 100 ml) and absorbance at 280 nm. 
Determination of Free Sulphydryl Groups 
The number of free sulphydryl groups in trypsin inhibitor was determined 
by the method of Ellman (1959) using Ellman's Reagent [5-5' dithiobis-2(nitrobe-
nzoic acid)] (DTNB) 
Samples containing DTNB concentration varying from 0.01 mg/'ml to 0.17 
mg/ml were prepared. The inhibitor concentration was kept constant at 0.75 mg/ml 
in all the samples. The samples were then incubated fc 10 minutes at room tempe-
rature. Absorbance of the samples were monitored at 412 nm. Optical density 
obtained was plotted against increasing molar ratio of DTNB to inhibitor. 
Determination of Neutral Hexoses 
Neutral hexoses were determined according to the method of Dubois 
(1956). To 1.0 ml inhibitor solution was added 1.0 ml of 5% redistilled phenol 
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solution and mixed thoroughly. 5.0 ml of concentrated sulphuric acid (96%) was 
added directly to the tubes. The tubes were then allowed to cool. The red orange 
colour obtained was read at at 490 nm against an appropriate blank. Hexose con-
tent was determined by least squares analysis using the standard curve of glucose. 
Determination of Sialic Acid 
The sialic acid content of aiantitrypsin was estimated by the method of 
Warren (1959) using N-acetylneuraminic acid as standard. 
The inhibitor (aiAT) was heated with O.IN sulphuric acid in a boiling 
water bath for one hour and released sialic acid was estimated. For the determi-
nation of sialic acid 0.5 ml of this solution was mixed with 0.1 ml of 0.2M sodium 
metaperiodate in 9M orthophosphoric acid and kept at room temperature for 20 
minutes. Then 1.0 ml of 10% (w/v) sodium arsenite (in a solution of 0.5M sodium 
sulphate and 0. IN H2SO4) was added with continous shaking until a yellow colour 
appeared and then disappeared. After this 3 ml of 0.6% (w/v) thiobarbituric acid 
(in solution of 0.5 M sodiimi sulphate) was added and the mixture was heated for 
15 minutes in a boiling water bath. After cooling equal volume of cyclohexanone 
was added and centrifuged at 2000 rpm for 20 minutes. The colour intensity of 
cyclohexanone layer was read at 550 imi using an appropriate blank. 
Functional Analysis 
Functional analysis of ajantitrypsin was carried out by determining the 
caseinolytic activities of bovine trypsin, porcine pancreatic elastase and bovine 
chymotrypsin in the presence of increasing concentration of ai antitrypsin. 
Caseinolytic activity of proteinases was determined by incubating 0.625 
^M trypsin (0.527 fiM of elatase and 1.88 i^M chymotrypsin) with 0.17- 2.5 ^M 
of buffalo serum ajantityrpsin in 0.02 M Tris HCl buffer pH 8.2 for 30 minutes at 
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room temperature. To the mixture was then added 1 ml of 1% casein and further 
incubated at 3/C for 45 minutes. The reaction mixture was then precipitated with 
6% TCA and inhibitory activity was then computed using the equation (Salahu-
ddin, 1991). 
A -A' Percent inhibition = '. x 100 (4) 
where A: Absorbance of control (absence of inhibitor) A': Absorbance of solution 
in presence of inhibitor. 
Measurements of Trypsin Inhibitory Activity of Buffalo Serum aiAnt-
itrypsin at Varying Concentration of Denaturants. 
Samples containing varying amount urea (1-9M) and guanidine (1-6M) 
hydrochloride denatured buffalo serum aiantitrypsin were prepared. Percent inhi-
bition at each concentration was obtained using BAPNA as substrate and trypsin 
as enzyme (Waheed and Salahuddin, 1975) using a standard which had the same 
composition as the reaction mixture minus the respective denaturant. Percent inhi-
bition obtained was plotted against increasing denaturant concentration (urea and 
Guanidine hydrochloride). 
Solvent Perturbation Studies 
Solvent perturbation difference spectral studies on buffalo serum aiantit-
rypsin were carried out in 0.2 M Tris HCl buffer pH 8.2 (Laskowski, 1966) using 
20% (v/v) dimethyl suphoxide as perturbing solvent. Studies were performed using 
both urea and guanidine hydrochloride as denaturant. Difference spectra of native 
buffalo serum aiantitrypsin and denatured aiantitrypsin with and without 20% 
(v/v) DMSO were obtained in the wavelength range 250-310 nm using 9 M urea 
and 6M Gu HCl as denaturant. Solvent perturbation difference spectrum in each 
case was obtained by plotting A A/A values at each wavelength against increase in 
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wavelength where AA is the difference in absorbance at each wavelength and A is 
the absorbance at Xmax. 
Denaturation Studies 
The urea/guanidine hydrochloride denaturation of buffalo serum aiantitr-
ypsin was studied by UV difference spectroscopy. The urea/guanidine hydroch-
loride induced difference spectrum was obtained by subtracting the absorbance of 
protein in 0.06M sodium phosphate buffer, pH 7.0, Is= 0.15 from the absorbance 
of protein in 9M urea and 6M guanidine hydrochloride in the wavelength range 
240-360 nm. For transition studies buffalo serum aj antitrypsin was treated with 
increasing concentrations of urea varying between 1.0 and 9.0 M. Similarly for 
transition studies another set of samples were prepared treated with increasing 
concentrations of guanidine hydrochloride varying between 0.5 to 6M. Same pro-
cedure was applied for sample preparation irrespective of the denaturant used. For 
a particular transition point, a required amount of denaturant (urea/guanidine hydr-
ochloride) was delivered into a 5.0 ml cahbrated volumetric flask. 1.0 ml of pro-
tein solution was transferred into flask and volume was made upto 5.0 ml with 
water. The contents were thoroughly mixed and incubated for 8 hours at 25°C. A 
native protein control containing identical amount of protein in sodium phosphate 
buffer, pH 7.0, Is = 0.15 and a denaturant blank containing an identical amount of 
denaturant but no protein in same buffer were also prepared. Absorbance of pro-
tein in urea and aborbance of protein in guanidine hydrochloride was recorded 
against their respective blanks (denaturant blank) and that of native protein against 
buffer at 286 nm. For scattering corrections absorbance was recorded in the wave-
length range 330-350 nm and extrapolated to 286 nm. A O.D. (286) was obtained 
in both cases by subtracting the absorbance of protein in buffer from the absor-
bance of an identical amount of protein in appropriate denaturant (urea or guani-
dine hydrochloride). Protein concentration was 1.7 mg/ml. 
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A single parameter A O.D. (286) ( y ) was used for measuring urea or 
guanidine hydrochloride induced unfolding of buffalo serum aiantitrypsin. Values 
of y characteristic of native state (YN) and denatured state (YD) were obtained by 
extrapolation of linear portion of urea and guanidine hydrochloride denaturation 
curves at low and high concentrations into the transition region (Mathews and 
Crisanti, 1981; Pace, 1986). The transition curves were analysed by established 
procedure (Tanford, 1968, Pace, 1986). 
At any point in the transition region 
fD = (Y-YN)/(YD-YN) (5) 
where fo is the transition of unfolded (denatured) protein at a particular urea or 
guanidine hydrochloride concentration. For each transition point and equilibrium 
constant, K^ was obtained from the equation. 
KD = fD/l-fD (6) 
From the value of equilibrium constant KD, apparent free energy difference (AGD) 
between native and unfolded state was calculated using equation 
AGD = -RT hiKo (7) 
The free energy of stabilization (AGD "2°), a measure of stability of protein in its 
folded state (in absence of denaturant) was obtained by linear extrapolation model 
(Tanford, 1970 ; Pace, 1975 and 1986). 
Fluorescence Measurements 
Fluorescence excitation and emission spectra of native buffalo serum aj 
antitrypsin, 9M urea denatured and 6M guanidine hydrochloride denatured ajanti-
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trypsin were carried out using 0.06M sodium phosphate buffer, pH 7.0, Is = 0.15. 
Tryptophan fluorescence of native, 9M urea denatured and 6M guanidine hydroc-
hloride denatured aj antitrypsin were recorded using excitation wavelength of 
290nni. To study the effect of denaturant on fluorescence intensity of ajantitryp-
sin, samples containing varying concentration of urea denatured and guanidine 
hydrochloride denatured buffalo serum ai antitrypsin were prepared. Urea concen-
tration was kept between 1-9M and guanidine hydrochloride concentration was 
kept between 1-6M. Fluorescence intensity of each samples was measured at emis-
sion maxima of native aiantitrypsin. Fluorescence intensity obtained was plotted 
against increase in denaturant concentration. 
Stoichiometry 
The stoichiometry of enzyme trypsin binding to buffalo serum aiantitryp-
sin was determmed b> incubating increasing concentration of a i antitrypsin (0.16 
)iM- 1.44 )iM) with 0.433 \xM of trypsin. Substrate used was BAPNA the concent-
ration of which was kept constant. The samples were read against appropriate 
blank. Percent inhibition was calculated with respect to a standard which conta-
ined trypsin but no inhibitor as already described earlier. Percent inhibition was 
plotted against jiM of ai antitrypsin (inhibitor). 
RESULTS 
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RESULTS 
Buffalo ttiantitrypsin was isolated from serum extracted from fresh blood 
brought from slaughter house. Isolation of aiantitrypsin was done by salt fraction-
ation and further purification was done by ion exchange chromatography on DEA-
E-Sephacel column. Protein concentration at each step was monitored by the meth-
od of Lowry et a/. (1951) usmg BSA as standard (Fig. 2). About 300 ml of serum 
containing about 25,200 mg of protein was subjected to 30% ammonium sulphate 
fractionation. Inhibitory activity measurements of both the supernatant and the pre-
cipitate showed the presence of significant antitryptic activity in the supernatant. 
The supernatant was made 50% with respect to ammonium sulphate. Again the 
supernatant showed higher antitryptic activity than the precipitate. The supernatant 
was made 80% with respect to ammonium sulphate. The supernatant and the preci-
pitate were again tested for antitryptic activity'. Antitryptic activity measurements 
at each step were performed according to the method described in the experimental 
section and was found to be maximum in 80% precipitate. Various isolation and 
purification results are summarized in Table VI. The precipitated protein was fiir-
ther purified b> ion exchange chromatography on DEAE-Sephacel column equili-
brated with 0.03M sodium phosphate buffer pH 6.2, Is = 0.042. The unbound pro-
tein was eluted with 0.03M sodium phosphate buffer pH 6.2, Is = 0.042. The 
protein bound to the column was eluted batchwise using buffer of increasing ionic 
strengths as shown in the elution profile (Fig. 3). As showTi peak I was eluted with 
buffer of Is = 0.1 and peak II was eluted with buffer of Is = 0.2. Protein content of 
the peak I and peak II were also estimated by the method of Lowry ef al (195]). 
Peak I and II were tested for their antitryptic activity' and it was found that peak I 
showed inhibition per mg of protein to be 0.82 where as peak II showed inhibition 
per milligram to be 23.23. Comparison of the above two values indicate nearly 40-
fold increase in inhibitory acti\ity. Final protein yield after ion exchange chroma-
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Fig. 2. 
0.08 0.12 0.16 0.20 
Amount of protein (mg) 
Calibration curve for the estimation of protein using BSA as stand-
ard (Lowry et aLy 1951). 
Straight line was drawn by least square analysis using the equation : 
(Absorbance) 7oonni = 154 (mg of protein) + 0.043 
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TABLE VI 
Isolation and Purification of Buffalo serum a antitrypsin 
Purification steps Vol. Total Inhibition/ % Protein Fold 
(ml) Ptotein (mg) mg Yeild Purification 
Serum 300 25,200 0.59 100 1 
80% ammonium 150 5,760 1.22 22.9 2.07 
sulphate fraction 
Ion exchange 200 340 23.23 1.35 39.38 
chromatography 
(DEAE-Sephacel) 
peak II 
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tography was 1.35% of the total protein present in serum i.e. 25,200 mg. Thus 
about 340 mg of aj antitrypsin was obtained from about 300 ml of buffalo serum. 
When ai antitrypsin obtained after ion exchange chromatography was 
electrophoresed in Tris glycine buffer, pH 8.2 on 10% polyacrylamide gel (Davis 
1964), it was found to be slightly impure. (Fig. 4) shows the polyacrylamide gel 
electrophoretic pattern of 80% ammonium sulphate fraction (A & A'). Peak 1 
(B & B') and peak 11 (C & C). Peak 11 shows some microheterogeneity hence it 
was further purified by rechromatography on the same DEAE-Sephacel column 
under identical conditions (Fig. 5.). 
When the purified aj antitrypsin i.e. rechromatographed peak 11 was elec-
trophoresed in Tris glycine buffer pH 8.2 on 10% polyacrylamide gel (Davis, 
1964) a single band was obtained (Fig. 6.) suggesting that buffalo serum ai anti-
trypsin is homogeneous with respect to charge. Zone broadening or tailing might 
be due to the glycoprotein nature of the inhibitor. When the inhibitor was passed 
through Sephacryl S-200HR column equilibrated in 0.06M sodium phosphate 
buffer, pH 7.0, Is = 0.15 it eluted as a single symmetrical peak (Fig. 7). The inhi-
bitor was also found to elute in a single symmetrical peak when subjected to 
HPLC gel filtration (Fig. 8). These observations taken together with the fact that 
the inhibitor migrates as a single band when subjected to sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (Laemellie, 1970) under reducing conditions 
(Fig. 9) suggest that buffalo serum aj antitrypsin is homogenous with respect to 
size and consists of a single polypeptide chain. Hence, the fractions obtained after 
rechromatography were pooled and used for further studies. 
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A A' B B' c c 
il 
Fig. 4. Polyacrylamide gel electrophoretic pattern of 80% ammoiiium sulp-
hate fraction (A & A') compared with peak I (B <& B') and peak II 
(C & C). 
Samples were applied in duplicate concentration of which were 13jig, 
6)ag and 14)ig respectively. Current of 3 mA was applied per well. 
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Fig. 5. Elution profile of rechromatographed peak II on an ion exchange 
column using DEAE-Sephacel. 
Conditions were the same as described in legend to Fig. 3. 
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Fig. 6. Polyacrylamide gel electrophoretic pattern of rcchromatographed 
peak II on 10% gel. 
About 14ng (A & A') and 9|ag (B & B') of the sample were applied. 
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Fig. 7. Elution profile of purified buffalo serum ajantitrypsin on Sephacryl 
S-200HR column (63 x 1.61 cm). 
About 10 mg of a 1 antitrypsin obtained by ion exchange chromatograp-
hy (Peak II) was applied on the column. Column was equilibrated with 
0.06M sodium phosphate buffer, pH 7.0, Is = 0.15 and was operated 
at a flow rate of 25 ml/ h. The column was monitored by the method 
ofLowTy <?/a/. (1951). 
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Fig. 9. Sodium dodecyl polyacrylamide gel electrophoresis of buffalo serum 
ai antitrypsin. 
About 8|ig (A) and lOjug (A') of aj antitrypsin was electrophoresed on 
10% gel in the presence of Tris glycine buffer, pH 8.3 containing 0.1% 
SDS. 
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Determination of Molecular Weight by SDS-PAGE 
The molecular weight of ai antitrypsin was determined by sodium dodecyl 
polyacrylamide gel electrophoresis in Tris glycine buffer pH 8.3 containing 0.1% 
SDS on 10% polyacrylamide gel according to the method of Laemelli (1970). 
The marker proteins used are listed in Table VII along with their molecu-
lar weights and relative mobility values (Rm). The maker proteins as well as the 
inhibitor were electrophoresed in identical conditions (Fig. 10). Rm values of 
marker proteins and inhibitor were determined as 
Distance trayellM by protein b^^^ 
Distance travelled by dye 
A straight line was drawn between log M (log Molecular weight) and Rm accor-
ding to the method of least square (Fig. 11) which fits the equation 
log M =-1.172 Rm +5.283 (8) 
Corresponding to the Rm value of 0.49 for ai antitrypsin the molecular weight of 
the inhibitor was calculated to be 51KDa with the help of the above equation (8). 
The molecular weight of ai antitrypsin was found to be in close agreement to the 
earher reported values (Crawford, 1973; Ganrot, 1972) while is slightly lower than 
the value reported by Potempa et al (1995). 
Determination of Specific Extinction Coefficient (E '^'^ i cm) 
Protein solutions of varying concentration (0.04 mg/ml - 0.16 mg/ml) were 
prepared and their absorbance measured at 280 nm. The slope of the curve drawn 
between absorbance at 280 imi and protein concentration in g/100ml (Fig. 12) as 
determined by least square analysis was found to be 5.05. Hence E'^ c^m of ai anti-
trypsin was 5.05 cm g^"' which is in close agreement to the E'°°icm value at 280 nm 
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TABLE VII 
Log M and Rm values of Markers Proteins and Buffalo serum 
aflntitrypsin Used in SDS-PAGE 
Proteins 
BSA (Dimer) 
BSA (monomer) 
Ovalbumin 
a-chymotrypsinogen 
Cytochrome c 
a, antitrypsin 
Molecular weight (M) 
132,000" 
68,000" 
45,000'-
25,000= 
12,000'* 
Log M 
5.12 
4.84 
4.65 
4.40 
4.09 
Rm 
0.28 
0.43 
0.57 
0.75 
0.92 
0.49 
a. Tanford(1968) 
b. Castello and Barker (1968) 
c. Weber and Osbom (1969) 
d. Andrews (1970) 
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Fig. 10. Sodium dodecyl polyacryiamide gel electrophone pattern of marker 
proteins BSA dimer (1), BSA monomer (2), Ovalbumin (3), a-Chy-
motrypsinogen (4), Cytochrome c (5) and Inhibitor (6). 
Conditions were the same as described in legend to Fig. 9. 
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Fig. 11. Plot of LogM versus Relative mobility values (Rm) of mariner 
proteins and Ui antitrypsin. 
The marker proteins are denoted by (#). Buffalo serum aiantitrypsin is 
denoted by (O) Marker proteins used were: 
1. BSA(dimer) 2. BSA (monomer) 3. Ovalbumin 
4. a-Chymotrypsinogen 5. Cytochrome c 
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Standard plot for determination of specific extinction coefficient of 
buffalo serum a j antitrypsin at 280 nm. 
Inset : Shows the UV absorption spectrum of native buffalo serum 
ttiantitrypsin in 0.06M sodium phosphate buffer, pH 7.0, Is = 0.15. 
Values represent a mean of four determinations carried out in dupl-
icates and in no case the deviation observed was more than five 
percent. 
58 
reported by Crawford (1973) i.e. 4.36 cmV' and E'°°,cn, (278 nm) value of 5.3 
cm^g' reported by Schonenberger (1955). 
Estimation of Free Sulphydryl Groups in aiantitrypsin 
The number of free sulphydryl groups in aiantitrypsin were determined by 
Elhnan's method (1959) in O.IM sodium phosphate buffer, pH 8.0. The absorb-
ance at 412 nm was plotted against increasing molar ratio of DTNB to aiantitr-
ypsin (protein). The inflection point in the curve ( Fig. 13) occurs at DTNB to 
protein molar ratio of 1.9 suggesting the presence of two free sulphydryl groups in 
aiantitrypsin. The value obtained was in close agreement with the earber reports 
in human aiantitrypsin (Heimburger et al., 1971 and Crawford, 1973). 
Estimation of Total Carbohydrate Content 
(i) Estimation of neutral hexose 
Neutral hexose content of ai antitrypsin was determined by the method of 
Dubois et al. (1956) and was determined by computing the values of aiantitrypsin 
with standard curve of glucose (Fig. 14). The straight line obtained in case of stan-
dard curve fits the equation 
(Absorbance)49o „m ~ 4.66 (mg of hexose) + 0.0322 (9) 
Neutral hexose content from the above equation (9) was found to be 10.9%. 
(ii) Estimation of sialic acid 
Sialic acid content of aiantitrypsin was estimated by the method of 
Warren (1959) and was found to be 2.6% (Fig. 15) using equation (10) shown in 
the legend to Fig. 15. 
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DTNB titration curve for estimation of the number of free 
sulphydryl groups. 
A fixed amount of inhibitor (0.0043 mM) was incubated with increas-
ing concentration of DTNB. Absorbance at 412 nm was plotted against 
increasing DTNB protein (inhibitor) molar ratio. Values represent a 
mean of five determinations carried out in triplicate. 
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Fig. 14. A standard plot of glucose for the estimation of neutral hexose by 
the method of Dubois et al. (1956). 
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Standard plot for the estimation of sialic acid by the method of 
Warren (1959). 
N-acetylneuraminic acid was used as standard. The straight line obtain-
ed by the method of least square fits the equation : 
(Absorbance)55o nm = 11 72 (mg of sialic acid) + 0.016 
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Hence buffalo serum aiantitrypsin contains about 13.5% carbohydrate 
residues by weight which is in close agreement Avith the earlier reported values 
of carbohydrate present in human (Crawford, 1973) and goat ai antitrypsin (Salah-
uddin, 1991). 
Functional Properties 
Functional properties were analyzed by determining the effect of buffalo 
serum ai antitrypsin on the caseinolytic activity of bovine trypsin, bovine chymo-
trypsin and porcine pancreatic elastase. The inhibitor was found to appreciably 
inhibit the caseinolytic activity of bovine trypsin and porcine pancreatic elastase. It 
was observed that when bovine trypsin was incubated with 0.17- 2.5 fxM (Fig. 16) 
of buffalo serum ai antitrypsin about 85% inhibition of the caseinolytic activity of 
the proteinase was obtained at the inhibitor : enzyme ratio of 1 : 1. Similar treat-
ment of porcine pancreatic elastase indicated about 65% (Fig. 17) inhibition of the 
caseinolytic activity of elastase at the inhibitor ; enzyme ratio of 1 : 1. While only 
about 36% of the caseinolytic activity of bovine chymotrypsin was inhibited at the 
inhibitor : enzyme ratio of 1 : 1 (Fig. 18). 
Hydrodynamic Properties 
Hydrodynamic properties of buffalo serum aiantitrypsin were determined 
by analytical gel chromatography on Sephacryl S-200HR column equilibrated in 
0.06M sodium phosphate buffer, pH 7.0, Is = 0.15. 
The void volume of the column was determined by passing a band of blue 
dextran and the elution profile is shown in Fig. 19. The elution volume of blue 
dextran which is equal to the void volume (¥„) of the column was found to be 49 
ml. The iimer volume, V, was determined by passing 0.5% glucose solution. The 
elution profile is shown in Fig. 20. and its elution is given by 
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Fig. 16. Inhibition of trypsin by buffalo serum aiantitrypsin. 
Percent inhibition is plotted against increasing amount of aiantitryipsin 
(0.17 - 2.5 nM). Trypsin concentration was kept constant at 0.625 fiM. 
\% case-in was used as substrate. Values represent a mean of three det-
erminations carried out in triphcates and in no case was the difference 
found to be more than six percent. 
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Fig. 17. Inhibition of elastase by buffalo serum aiantitrypsin. 
About 0.527 )iM of elastase was incubated with increasing amount of 
buffalo serum aiantitrypsin (0.17 - 2.5 jiM) using 1% casein as substra-
te. Percent inhibition obtained was plotted against amount of inhibitor 
(aiantitrypsin). Values represent a mean of three determinations carried 
out in triplicates and in no case the difference found to be more than six 
percent. 
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Fig. 18. Inhibition of chymotrypsin by buffalo ai antitrypsin. 
Conditions were the same as described earlier in Fig. 16 except that ch-
motrypsin concentration was kept constant at 1.88^M. Values represent 
a mean of three determinations carried out in triplicates and in no case 
was the difference found to be more than eight percent. 
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Fig. 19. Elution profile of blue dextran on Sephacryl S-200HR column (63 
\ 1.61 cm) equilibrated with 0.06M sodium phosphate buffer, pH 
7.0, Is = 0.15. 
10 mg of blue dextran in 2.0 ml of buffer was applied and the colour in-
tensity monitored at 625 nm. 
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Fig. 20. Elution profile of glucose on Sephacryl S-200HR column (63 \ 1.61 
cm) equilibrated with 0.06M sodium phosphate buffer, pH 7.0, 
Is = 0.15. 
8 mg of glucose in 1.5 ml of buffer was applied and fractions collected 
were monitored at 490 nm (Dubois et al., 1956). 
68 
V,(g) = Vo + K<,Vi (H) 
The value of distribution coefficient, Kd for glucose is 1.0 and the Ve(g) value was 
112 ml. Using these values V; was calculated to be 63 ml. The distribution coeffi-
cient, Kd and available distribution coefficient Kav for marker proteins and inhib-
itor were calculated using the following expressions 
Kd = (Vc-Vo)/V, (12) 
K.v = (Ve-Vo)/(V,-Vo) (13) 
The total volume of the column was determined to be 124 ml. The marker proteins 
used in gel filtration along with their Stokes radii and molecular weights are hsted 
in Table VIII. The elution profile of various maker proteins [BSA (dimer and mon-
omer), Ovalbumin, a-chymotrypsinogen and cytochrome c] and ai antitrypsin are 
depicted in Fig. 21. The elution volume of buffalo serum aj antitrypsin was calcu-
lated to be 67 ml fi-om the average of three readings. 
Following equations were used for the analysis of gel filtration data by the 
method of least square to determine the molecular weight 
VeA^ o = 0.205 log M + 0.422 (14) 
M^^  =-64.27iKd^^ + 82.36 (15) 
where M is the molecular weight of ajantitrypsin. The linear plots according to 
equations (14) and (15) are depicted in Fig. 22 and 23. The values of VeA^ o, log M 
and Kd'^  and M''^ for maker proteins and ai antitrypsin are given in Table IX. The 
value of VeA^ o of 1.37 for ai antitrypsin corresponds according to Fig. 22 to a 
molecular weight of 53KDa. From the linear plot shown in Fig. 23 the molecular 
weight was found to be 59.8KDa using the IQ ' ^ value for aiantitrypsin to be 0.67. 
The average of the values gave a molecular weight of 56.4 KDa for buffalo serum 
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TABLE VIII 
Values of Molecular Weights and Stokes Radii of Marker Proteins 
Marker protein 
BSA (dimer) 
BSA (monomer) 
Ovalbumin 
a-chymotrypsinogen 
Cytochrome c 
Molecular Weight 
(KDa) 
132 
68 
45 
25 
12 
Stokes radius* 
(nm) 
4.3 
3.5 
3.0 
2.29 
2.2 
•Taken from Andrews (1970), Tanford (1968) and Castello and Barker (1968). 
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Fig. 22. Analysis of gel filtration data of marker proteins and buffalo serum 
aiantitrypsin according to the method of Andrews (1970). 
Marker proteins used were : 1. BSA (dimer), 2. BSA (monomer), 
3. Ovalbumin, 4. a-Chymotrypsinogen, 5. Cytochrome c. 
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Fig. 23. Analysis of gel filtration data of marker proteins and buffalo serum 
aiantitrypsin according to the method of Porath (1963). 
Marker proteins used were : 1. BSA (dimer), 2. BSA (monomer), 
3. Ovalbumin, 4. a-Chymotrypsinogen, 5. Cytochrome c. 
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TABLE IX 
V/V^, Log M, KJ'^ and M"^ Values of Marker Proteins and Buffalo 
Serum a^ antitrypsin Used in Gel Filtration Experiments 
Proteins 
BSA (dimer) 
BSA (monomer) 
Ovalbimiin 
a chymotrypsinogen 
Cytochrome c 
a, antitrypsin 
c o 
1.24 
1.33 
1.43 
1.63 
1.93 
1.37 
LogM 
5.12 
4.83 
4.65 
4.40 
4.09 
-
K;-* 
0.57 
0.65 
0.70 
0.79 
0.98 
0.67 
JV|l/3 
51.29 
40.8 
35.5 
29.5 
22.7 
-
* Each value represents the a ^erage of four determinations carried out in triplicate 
and in no case was the difference obtained to be more than six percent. 
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ttiantitrypsin. The value (56.4 KDa) obtained by gel filtration is higher than the 
value obtained during SDS-PAGE (51 KDa). The values of IQ, Kav, erfc'Kd, and 
(-log Kav)^ ^ were calculated for marker proteins and aiantitrypsin and the results 
are summarized in Table X. 
Stokes radius of ai antitrypsin was determined by analyzing the gel filtra-
tion data according to the method of Ackers (1967) using the following equation 
erfc-*K<, = 0.19(r) +0.13 (16) 
where erfc'lQ is the error fimction complement of distribution factor of protein 
with Stokes radius (r). Least square analysis of a plot of erfc'lQ versus r yielded a 
straight line (Fig. 24). The value of erfc'^ IQ for ai antichymotrypsin was calcu-
lated to be 0.74 which according to equation (16) would correspond to Stokes 
radius (r)of3.21mn. 
Another plot was drawn according to Laurent and Killander (1964) betw-
een Stokes radius (r) and (-log Kav)'^  as shown in Fig. 25. Straight line obtained 
by least squares analysis fits the equation 
(-logKav)'^  = 0.019 (r) + 0.708 (17) 
The value of (-log Kav)' ^  of aiantitrypsin was found to be 0.7701 which according 
to equation (17) corresponds to Stokes radius (r) value of 3.26 nm. 
From the knowledge of Stokes radius (r), diffusion coefficient, D, of ai 
antitrypsin was calculated according to the equation (Andrews, 1970) 
D=KT/6rTir (18) 
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T A B L E X 
K^ K^ erfc'Kj and (-logK^, )'^ values of Marker Proteins and Buffalo 
Serum a Antitrypsin Used in Gel Filtration 
Proteins 
BSA (dimer) 
BSA (monomer) 
Ovalbumin 
a chymotrypsinogen 
Cytochrome c 
a, antitrypsin 
K. 
0.19 
0.27 
0.33 
0.49 
0.79 
0.30 
K 
av 
0.16 
0.22 
0.28 
0.41 
0.61 
0.25 
erfc'K^ 
0.94 
0.80 
0.72 
0.62 
0.45 
0.74 
(-logKJ^'^ 
0.8921 
0.8109 
0.7435 
0.6222 
0.4632 
0.7701 
Each value represents an average of four determinations carried out in triplicate. In 
no case the deviation obtained was more than four percent. 
76 
9i 
U) 
0-e 
06 
(W 
0-2 
-
5 / 
1 
A ^ 
%/ 
1 
3 . 
t 
2 y 
t / 
1 1 
2 3 
Stokes radius (nm) 
Fig. 24. Analysis of gel filtration data of mariner proteins and buffalo serum 
ai antitrypsin according to the method of Ackers (1967). 
Marker proteins used were : 1. BSA (dimer), 2. BSA (monomer), 
3. Ovalbumin, 4. a-Chymotrypsinogen, 5. Cytochrome c. 
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Fig. 25. Analysis of gel filtration data of marker proteins and buffalo serum 
ai antitrypsin according to the method of Laurent and Killander 
(1964). 
Marker proteins used were : 1. BSA (dimer), 2. BSA (monomer), 
3. Ovalbumin, 4 a-Chymotrypsinogen, 5. Cytochrome c. 
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where K is the Boltzmann constant, 11 is the coefficient of viscosity of the medium 
(i.e. 0.06 M sodium phosphate buffer, pH 7.0, Is = 0.15) and T is the absolute tem-
perature. Using values of K =1.386 x 10"^  ergs/ degs; TI = 0.01 poise, T = 298 K 
and from the determined value of r. The value of diffusion coefficient for ai anti-
trypsin was calculated to be 6.85 x 10'' cm /^ sec front equation (18). 
The frictional ratio f/fi, of the aiantitrypsin>»^as calculated using the rela-
tion shown below (Andrews, 1970) 
ff; = r/(3v2M/47iN)''^ (19) 
when N is Avogadro's number (6 023 x 10^ ^ per mole) and V2 is the partial speci-
fic volume of protein. The partial specific volumeiof buffalo serum aiantitrypsin 
was taken to be 0.728 same as that reported fot hilman ai antitrypsin (Crawford, 
1973). The molecular weight of buffalo serum ai antitrypsin was taken to be 
56.4KDa as determined by gel filtration. Using these values the frictional ration of 
aiantitr>'psin was calculated as 1.27 with the help of equation (19). 
Activity Measurements of aiantitrypsin at Varying Concentrations of 
Urea and Guanidine Hydrochloride 
The inhibitory activity measurements of buffalo serum aj antitrypsin were 
carried out at varying concentration of urea (1-9M) and the results are shown in 
Fig. 26. Percent inhibition was found to decrease gradually as the concentration of 
urea was increased and reaches a minimum value at 9M urea concentration, aiant-
itr>psin shows about 22% of trypsin inhibitor)^ activity at 9M urea concentration. 
Inhibitory activity measurements of buffalo serum aj antitrypsin at varying 
concentration of guanidine hydrochloride (1-6M) are shown in Fig. 27. As can be 
seen in the figure , there is rapid decrease in trypsin inhibitory activity of buffalo 
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Urea (M) 
Fig. 26. Acrivity profile of buffalo serum aiantitrypsin at varying urea 
concentration. 
Percent inhibition of trypsin in the presence of urea was plotted against 
urea concentration. Results represent a mean of four determinations ca-
rried out in duplicate and in no case the deviation observed was more 
than seven percent. 
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Fig. 27. Activity profile of buffalo serum aiantitrypsin at varying guanidine 
hydrochloride concentration (Gu HCI). 
Percent inhibition of trypsin in the presence of urea was plotted against 
guanidine hydrochloride concentration. Results represent a mean of 
four determinations carried out in triplicate and in no case the deviation 
observed was more than five percent. 
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serum ai antitrypsin as the concentration of guanidine hydrochloride is increased 
and it reaches 0 at about 5M guanidine hydrochloride concentration. Thus all the 
denaturation experiments were performed at 9M urea and 6M guanidine hydroc-
hloride. 
Solvent Perturbation Studies ^ 
Solvent perturbation difference spectra of native and 9M urea denatured 
buffalo serum aiantitrypsin are shown in Fig. 28 (A & B). Native and 6M guani-
dine hydrochloride denatured buffalo serum ai antitrypsin solvent perturbation 
difference spectra are shown in Fig. 29 (A & B). As can be seen AA/A values at 
286 nm in case of urea denatured inhibitor shows 66% exposure of aromatic amino 
acid residues while AA/A values at 292 nm indicate about 48% exposure of trypto-
phan residues. In case of 6M guanidine hydrochloride denatured inhibitor AA/A 
value at 286 nm suggest about 81% exposure of aromatic amino acid residues 
while AA/A values at 292 nm indicate about 75% exposure of tryptophan residues. 
Denaturation Studies 
(i) Thermodynamic analysis of urea induced denaturation curve of buffalo 
serum U] antitrypsin : 
Urea induced denaturation of ai antitrypsin was studied by ultraviolet diff-
erence spectroscopy. Ultraviolet absorption spectra of native and 9M urea dena-
tured ttiantitrypsin are shown in Fig. 30. The absorption spectrum of native aianti-
trypsin shows a peak at 279 nm and a trough at 265 nm, while the absorption 
spectrum of 9M urea denatured inhibitor indicates a detectable blue shift by posse-
ssing a peak at 276 nm. The blue shift in denatured sample occurs most likely due 
to conformational changes and exposure of chromophores as suggested by Yanari 
andBovery in 1960. 
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Fig. 30. UV absorption spectra of native buffalo serum aiantitrypsin 
(k—4) and 9M urea denatured aiantitrypsin (•—•) in 0.06M sodi-
um phosphate buffer, pH 7.0, Is = 0.15. 
Inset: Urea induced difference spectrum of buffalo aiantitrypsin in 9M 
urea. Difference spectrum was obtained by substracting the absorbance 
of native aiantitrypsin from that of aiantitrypsin in 9M urea. 
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The difference spectrum obtained by subtracting the absorbance spectrum 
of native ai antitrypsin from that of 9M urea denatured aiantitrypsin is shown in 
inset of Fig. 30. The difference spectra shows a clear cut trough at 286imi and a 
shoulder at 282 nm. 
Urea induced transition in buffalo serum ai antitrypsin was studied at 
different urea concentration in the range 1 to 9M. The parameter for unfolding (y) 
was A O.D. (286 nm) [difference in absorbance at 286 nm of native and unfolded 
state]. The A O.D. (286 rmi) values for aiantitrypsin were plotted against urea con-
centration. The values characteristic of native state (YN) and unfolded or denatured 
state (YD) were obtained by extrapolation of linear portion of pretransition and post 
transition regions (Pace, 1986) into the transition region. The fraction denatured 
(fo) at each urea concentration was calculated with the help of equation (5). 
The transition curves for aiantitrypsin was constructed by plotting fo 
versus urea concentration (Fig. 31). It can be seen from the curve that denaturation 
of aiantitrypsin started at around 2.0 M and was nearly complete at 7M urea con-
centrations. The transition curve appears to be a two state process. 
The urea induced transition data were analyzed according to the method 
given by Tanford in 1968 and Pace in 1975 and 1986. The aim of this analysis is 
to determine the free energy of unfolding of aiantitrypsin in 9M urea. At each 
transition point an equilibrium constant (KD) between folded and unfolded state 
and free energy change was calculated using equations (6) and (7). 
The free energy change in the absence of urea (AGD"2*^) was calculated 
using the linear plot between AGD and urea concentration (Fig. 32). Least square 
analysis of the data fits the equation 
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Fig. 31. Urea induced transition curve of buffalo serum ai antitrypsin. 
Fraction denatured at urea concentration was calculated using equation 
(5). 
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Fig. 32. Plot of AGD versus urea concentration. 
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AGD = AGD "2 - m(urea) (20) 
The (AGD"2°) value from this plot as calculated from the intercept of Y-axis was 
found to be 3.17 Kcal/ mole. In equation (20) 'm' is a measure of the dependence 
of AGD on denaturant concentration and was calculated to be 0.95 Kcal/ mole. Di 2 
the denaturant concentration at midpoint of unfolding curve was found to be 
3.39M. 
(ii) Thermodynamic analysis of guanidine hydrochloride denaturation curve of 
buffalo serum Ui antitrypsin : 
Guanidine hydrochloride induced denaturatioin of a 1 antitrypsin was stu-
died by UV difference spectroscopy. The UV difference spectrum of ai antitrypsin 
in 6M guanidine hydrochloride is shown in Fig. 33. The spectrum is characterized 
by trough at 286 run, shoulder at 281 nm and another trough in the 290-292 nm 
range. 
Guanidine hydrochloride induced transition in buffalo serum aiantitryp-
sin was studied at different guanidine hydrochloride concentrations in the range 1-
6M. The parameter of unfoldmg (y) was AO.D. (286nm). AO.D (286nm) were pl-
otted against guanidine hydrochloride (increasing concentration), y^ and yn values 
were obtained as already described in the section on urea induced denaturation 
curve analysis. 
Fraction denatured (fo) values obtained using equation (5) were plotted 
against guanidine hydrochloride concentrations (Fig. 34). It can be seen that dena-
turation starts at about 1.2M guanidine hydrochloride concentration and is nearly 
total at about 5.0M guanidme hydrochloride concentration. As observed for urea 
transition curve the guanidine hydrochloride transition curve also appears to be a 
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Fig. 33. Gu HCl induced difference spectrum of buffalo serum ai antitrypsin 
in 6M Gu HCl. 
Difference spectrum was obtained by substracting the absorbance of 
native aiantitrypsin from that of aiantitrypsin in 6M Gu HCl. 
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Fig. 34. Gu HCI induced transition curve of buffalo serum aiantitrypsin. 
Fraction denatured at Gu HCI concentration was calculated using equa-
tion (5). 
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two state process. The guanidine hydrochloride induced transition were also analy-
zed according to the method given by Tanford in 1968 and Pace in 1975 and 1986. 
The free energy change in the absence of guanidine hydrochloride (AGD 2 ) was 
calculated using the plot AGD versus guanidine hydrochloride concentration (Fig. 
35) using the equations (6) and (7) for determination of AGD and KD values. Least 
square analysis of the data in Fig. 35 fits the equation (20). The AGD 2 value 
from this plot as calculated from the intercept on Y-axis was found to be 3.41 
Kcal/ mole, 'm' the value of measure of dependence of AGD on denaturant concen-
trations was calculated to be 1.19 Kcal/ mole. Denaturant concentration at the mid-
point of transition was found to be 2.24M. 
Data obtained during analysis of urea denaturation curve and guanidine 
hydrochloride denaturation curve are summarized in Table XI. 
Fluorescence Measurements 
The excitation and emission spectra obtained in wavelength range 220-300 
nm and 300-400 nm (Fig. 36 A & B) of native buffalo serum aiantitrypsin show 
excitation wavelength used was 276 nm and emission maxima was obtained at 
about 336 nm. These results indicate the presence of tryptophan residues in ai 
antitrypsin. 
Tryptophan fluorescence was excited at 290 nm and used as an additional 
probe to determine the conformational change. The fluorescence emission spectra 
obtained (Fig. 37 A, B, C) show emission maxima of native aiantitrypsin to be 
337 nm (Fig. 37A), emission maxima of 6M guanidine hydrochloride denatured ai 
antitrypsin was found to be 345 nm (Fig. 37C) and emission maxima of a 9iM urea 
denatured aiantitrypsin was found to be 335 nm (Fig. 37B). A large red shift of 
maxima of emission spectra from 337 nm for native aiantitrypsin to 345 nm in 6M 
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Fig. 35. Plot of AGD versus Gu HCI concentration. 
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TABLE XI 
Parameters Characterizing the Urea and Guanidine hydrochloride 
Denaturation of Buffalo Serum a^ antitrypsin atpH 7.0, IS^C 
m (Kcal mol > M') I>„2(M) AG„«2" (Kcal MoH) 
Urea 0.95 ±0.31 3.39 3.17 ±0.48 
GuHCl 1.19 ±0.25 2.24 3.41±0.34 
m stands for measure of dependence of free energy change on denaturant 
concentration 
Dj 2 stands for midpoint of denaturation curve = AGp"2° /m 
94 
a 
w 
e 
s 
.2 
220 260 300 300 350 
Wavelength (nm) 
400 
Fig. 36. Fluorescence excitation (A) and emission (B) spectra of buffalo 
serum aiantitrypsin. 
Spectra was obtained in 0.06 M sodium phosphate buifer, pH 7.0, Is 
0.015. 
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Fig. 37. Tryptophan fluorescence showing emission maxima shifts and decr-
ease in fluorescence intensity of 9M urea (B) and 6M Gu HCl (C) 
denatured aiantitrypsin with respect to native aiantitrypsin (A). 
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guanidine hydrochloride was observed indicating exposure of tryptophan residues, 
while slight blue shift fi^om 337 nm to 335 nm and an increase in fluorescence 
intensity with respect to guanidine hydrochloride in 9M urea indicate exposure of 
chromophores and some conformational change. Fluorescence measurement resu-
lts are summarized in Table XII. 
Fluorescence intensity changes as observed at 337 nm (emission maxima) 
of native a i antitrypsin were plotted against different concentration of urea and 
guanidine hydrochloride (Fig. 38 & 39), there occurs a decrease in fluorescence 
intensity as the concentration of urea was gradually increased (Fig. 38). About 
34% decrease in fluorescence intensity was observed over the entire range range of 
urea concentration. Fig. 39 shows about 46% decrease in fluorescence intensity 
over entire range range of guanidine hydrochloride concentration. 
Circular Dichroism Spectra of Buffalo Serum aiantitrypsin 
The CD spectra in far UV range of native buffalo serum aj antitrypsin, 9M 
urea denatured aiantitrypsin and 6M guanidine hydrochloride denatured aiantitry-
psin are shown in Fig. 40 (1, 2 & 3). The solvent used was 0.12M sodium phos-
phate buffer, pH 7.3 using a quartz cell of 0.1 cm pathlength. 
Curve 1 shows the presence of a deep negative band at 222 nm and also a 
positive shoulder in the 194-196 nm range indicating the presence of significant a-
helical as well as p-sheet content in the native state. CD spectra of 9M urea dena-
tured aiantitrypsin (curve 2) shows a slight decrease in negative ellipticity com-
pared to native aiantitrypsin indicating a ^lightly disorganized main chain of the 
inhibitor. On the other hand, CD spectra of 6M guanidine hydrochloride denatured 
ai antitrypsin (curve 3) shows that main chain is fully denatured. 
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TABLE XII 
Tryptophan Fluorescence emission maxima (Zmax) of Native, 9M Urea 
and 6M Guanidine hydrochloride Denatured Buffalo Serum a^ antitrypsin 
Xmax (nm) Fluorescence Intensity 
Native a,antitTypsin 
9M Urea denatured a, antitrypsin 
6M Gu HCI denatured a,antitrypsin 
The values of Amax and fluorescence intensity are average of three measurements. 
The de\iations of A,max = ± Inm and of fluorescence intensity ± 6%. 
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Fig. 38. Fluorescence intensity values at varying concentration of urea. 
Fluorescence intensity changes were recorded at 337nm (emission max-
ima of native aj antitrypsin). Results represent a mean of four recordin-
gs carried out in triplicate and the difference obtained was less than six 
percent. 
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Fig. 39. Fluorescence intensity values at varying concentration of Gu HCI. 
Fluorescence intensity changes were recorded at 337nm (emission max-
ima of native aiantitrypsin). Results represent a mean of four recordin-
gs carried out in triplicate and the difference obtained was less than six 
percent. 
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Fig. 40. CD spectra of the solutions of buffalo serum aiantitrypsin in far 
Ultraviolet zone. 
1. Native buffalo serum aiantitrypsin 
2. 9M urea denatured buffalo serum aiantitrypsin 
3. 6M guanidine hydrochloride denatured buffalo serum 
aiantitrypsin 
All the curves were constructed from three recordings. Optical path 
used was 0.1 cm. 
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Stoichiometry of Trypsin Binding to Buffalo Serum aiantitrypsin 
This experiment was performed to determine the number of moles of try-
psin bound per mole of inhibitor when the inhibitor was present in excess. Samp-
les were prepared which contained increasing concentration of inhibitor and fixed 
concentration of trypsin (0.433nM) and synthetic substrate BAPNA as already 
described in the experimental section. Percent inhibition obtained was plotted 
against increasing inhibitor concentration (Fig. 41). As observed from the figure 
the inflection point occurs at 0.543 jiM of inhibitor. The data obtained gave a stoi-
chiometry of 0.80 moles of trypsin bindmg to 1 mole of inhibitor which is closer 
to 1.1 molar ratio reported for a] antitrypsin (Bundy and Mehl, 1959). 
Kinetic Parameters 
Kinetic parameters. Km and Vmax were determined for buffalo serum ai 
antitrypsin using synthetic substrate BAPNA. Samples were prepared containing 
different substrate concentration (2 x 10 M to 9 x 10' M) and incubated with a 
fixed concentration of enzyme (8.75 x 10"^ M). Substrate saturation curve obtained 
is shown in Fig. 42. Vmax was found to be 0.116 OD units from Fig. 42. Km 
value was calculated to be 1.10 x 10" M. The velocity (V) values were calculated 
using the Michaelis Menten equation 
.,_ [S] Vmax 
^^fl t- i^max 
The data obtained were treated according to the Lineweaver-Burk (1934) plot [Fig 
43 (1& 2)] the 1/[S] versus lA' plot obtained by least square analysis gave the 
values of Km for free trypsin [Fig. 43 (1)] to be 1.10 x 10"'' M. 1/[S] versus lA^ 
plot for inhibited trypsin [Fig. 43 (2)] indicate a Km value of inhibited trypsin to 
be 2.0 X 10" M which is in good agreement with the earlier reported values and lies 
well within the range 0.17- 5.1 X 10"^ M (Bechet et ai, 1966; Inagami, 1964). 
102 
0.2 0.4 0.6 0.8 1.0 
Amount of ai antitrypsin (^M) 
1.2 1.4 
Fig. 41. Plot showing stoichiometry of trypsin binding to buffalo serum aja-
antitrypsin (inhibitor) 
Inhibitor concentration was varied from 0.08 jiM to 1.44 |iM. Amount 
of trypsin and substrate was kept constant. 
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Fig. 42. Substrate saturation curve 
Amount of trypsin was kept constant. 
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Fig. 43. Double reciprocal plot (Lineweaver-Burk plot) 
1. Free trypsin 
2. Inhibited trypsin 
DISCUSSION 
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DISCUSSION 
ai antitrypsin was isolated from buffalo serum by ammonium sulphate fra-
ctionation followed by purification by ion exchange chromatography, aj antitrypsin 
isolated was found to be free from extraneous proteins as indicated botii by the 
presence of a single band during polyacrylamide gel electrophoresis and also by 
tiie presence of a single peak obtained during HPLC gel filtration taken together 
with the fact that it migrates as a single sharp band in sodium dodecyl sulphate 
polyacrylamide gel electrophoresis in Tris glycine buffer, pH 8.3. Ammonium sul-
phate fractionation and ion exchange chromatography on DEAE-Sephacel column 
equihbrated with 0.03M sodium phosphate buffer, pH 6.8, Is = 0.042 resulted in 
removal of all the major serum proteins. In this respect the present procedure dif-
fers from other method used earUer for isolation of ai antitrypsin from goat plasma 
which required additional steps for purification (Potempa et al, 1995) which inc-
luded affinity chromatography. In the procedure described here the only additional 
steps for obtaining pure aiantitrypsin was rechromatographay of the inhibitor 
obtained after ion exchange chromatography that too on the same ion exchange 
column under identical conditions. The present procedure does not involve the ex-
posure of buffalo serum aiantitrypsin to pH less then 7.0 at 25"C, while on the 
other hand goat plasma aiantitrypsin was exposed to pH 4.5 during isolation 
(Salahuddin, 1991). Thus it can be said that the above described method of isola-
tion and purification of buffalo serum aiantitrypsin does not require extremes of 
pH, no solvent exposure and no extremes of temperature. 
The inhibitor was eluted with 0.03M sodium phosphate buffer, pH 6.8 Is = 
0.2. The purified inhibitor was found to be homogenous both with respect to 
charge and size as observed from the presence of single symmetrical band both in 
PAGE and SDS-PAGE, further confirmed by the presence of a single symmetrical 
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peak both during gel filtration on Sephacryl S-200 HR column and HPLC gel 
filtration. 
Buffalo serum ai antitrypsin has a molecular weight of 5lKDa as deter-
mined by sodium dodecyl sulphate polyacrylamide gel electrophoresis. The puri-
fied inhibitor gave a single band both under reducing and non reducing conditions, 
which also suggested the presence of a single polypeptide chain. Similar values of 
molecular weight (50 -56 KDa) were reported for aiantitrypsin isolated fi-om vari-
ous mammalian species by sodium dodecyl polyacrylamide gel electrophoresis 
(Crawford 1973; Chan et al, 1973; Salahuddin, 1991; Potempa et ai, 1995) and a 
molecular weight of 49.5 KDa has been reported by Crawford in 1973 using sedi-
mentation equilibrium method. Comparison of the values obtained by sodium dod-
ecyl sulphate polyacrylamide gel electrophoresis and determination of molecular 
weight by sedimentation equilibrium in case of human a i antitrypsin (Crawford, 
1973) suggests a single polypeptide chain structure for human ai antitrypsin. Thus 
structurally buffalo serum aiantitrypsin can be said to be related to human aianti-
trypsin. 
The ultraviolet light absorption spectra of buffalo serum aiantitrypsin 
studied in 0.06M sodium phosphate buffer, pH 7.0, Is = 0.15 showed maximum 
absorption to occur near 280 nm where the specific extinction coefficient was det-
ermined to be 5.05 cm^g"' . The value obtained was found to be 8% higher than the 
value obtained at 280 nm obtained for goat (4.58 cm^g"') and mouse aiantitrypsin 
(4.61 cmV') while it is about 13% higher than the value (4.36 cm^g') obtained for 
human aiantitrypsin (Crawford, 1973) but otherwise is in close agreement with 
values (4.8 - 5.3) reported at 280 nm for human and rabbit aiantitrypsin (Salahud-
din, 1991; Takahara and Sinohara, 1982; Musiani and Tomasi, 1976; Takahara and 
Sinohara, 1983; Koj et al., 1978). 
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Buffalo serum aiantitrypsin isolated in this study was found to be a sialo-
glycoprotein which has 10.9% neutral hexose and about 2.6% sialic acid residues. 
Crawford in 1973 reported the presence of about 11.5% carbohydrates in human 
tt]antitrypsin. Earlier studies carried out (Takahara and Sinohara, 1982; Koj et al., 
1978; Roll and Glew,1981) reported the presence of about 11-13% carbohy-drate 
in human aiantitrypsin, rat aiantitrypsin, rabbit aiantitrypsin and goat aiant-
itrypsin. The goat aj antitrypsin was shown to be devoid of sialic acid (Salahuddin, 
1991). Comparison of the half life of carbohydrate devoid aiantitrypsin with carb-
ohydrate containing aj antitrypsin was shown to decrease (Weber, 1985) hence 
presence of carbohydrate moieties can be said to be must for the survival of the 
inhibitor in serum. 
Functional analysis of buffalo serum aiantitrypsin carried out in this 
thesis show nearly (85%) complete loss of casienolytic activity of bovine trypsin 
at the inhibitor trypsin ratio of 1:1. However a comparatively weak inhibition 
(65%) of the caseinolytic activity of porcine pancreatic elastase was shown to 
occur at the inhibitor : elastase ratio of 1:1. Further only about 36% of the casei-
nolytic activity of the enzyme chymotrypsin occurs at the inhibitor : chymotrypsin 
ratio of 1:1 as shown in the present study. The functional analysis data suggest that 
the buffalo serum aiantitrypsin acts as an effective inhibitor of bovine trypsin and 
was mode-rately effective against elastase but acts as a poor inhibitor of bovine 
chymotrypsin. Functionally buffalo serum aiantitrypsin differs from human ai 
antitrypsin as the former acts against trypsin while the latter acts effectively agai-
nst elastase and chymotrypsin rather than trypsin (Travis et al., 1985; Travis and 
Salvesen, 1983). Functionally the inhibitor isolated in this thesis has been found 
to be similar to goat and sheep aiantitrypsin (Salahuddin, 1991; Sinha et al., 
1988) bo^ of "which are potent inhibitors of trypsin and elastase. 
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The gel filtration analysis of buffalo serum aiantitrypsin on Sephacryl S-
200 HR column gave a value of Stokes radius of the inhibitor to be 3.23imi and a 
molecular weight of 56.4 KDa. The value (56.4 KDa) of molecular weight obtai-
ned by gel filtration was found to be about 9% higher that the value (51 KDa) 
obtained for the inhibitor by SDS-PAGE in this thesis. The higher value of molec-
ular weight obtained by gel filtration was expected as the inhibitor contained about 
13.5% carbohydrates. Interestingly this discrepancy was found to be significantly 
lower than that observed earlier (15%) between the values of molecular weight by 
gel filtration and SDS-PAGE for proteinase inhibitor from horse seminal plasma 
which contained only about 4-5% of neutral hexose (van Fallenberg et al., 1985). 
The diffusion coefficient of the buffalo serum aiantitrypsin was found 
to be 6.85 x 10"^  cm^ sec' for which the frictional ratio ( f/f^ ) was found to be 
1.27. The values of D and f fo determined for the inhibitor taken together sugg-
est tiiat the native inhibitor molecule has a nonglobular conformation. Further, the 
deviation of ffo value from unity may be attributed excessive hydration of inhibi-
tor. This explanation appears to be a real possibility since buffalo serum aiantit-
rypsin being a sialoglycoprotein containing about 13.5% carbohydrate must be 
substantially hydrated . 
The inhibitory activity measurement at different concentration of urea 
show a gradual decrease in percent inhibition over entire range of urea concen-
tration . The not so steep decrease and the fact that the isolated buffalo serum 
aiantitrypsin in 9M urea still retains its capacity to inhibit trypsin (as already des-
cribed in results) indicates that the buffalo serum aiantitrypsin is a fairly stable 
and rigid molecule resisting the effect of high concentration of urea . Alternative-
ly, the inhibitory activity measurements over the entire range of guanidine hydro-
chloride concentration shows an abrupt decrease in percent inhibition value and it 
reaches zero at about 3M guanidine hydrochloride concentration. Taking into 
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account the above data one can be sure about the rigid structure of the inhibitor 
and non cooperative behaviour of the process of denaturation. Also on the basis of 
above data denaturation experiments were performed upto 9M urea and 6M guan-
idine hydrochloride concentration. 
Human aianitrypsin contains 2 tryptophan and 7 tyrosine residues (Craw-
ford 1973) per mole of the inhibitor. Denaturation in 9M and consequent exposu-
re of tyrosine residues produced a blue shift in the absorption spectrum. Presence 
of a trough at 286imi and a shoulder at 281nm in the difference spectra also sig-
nifies exposure of tyrosine residues while absence of any feature in the 290-292nm 
range in difference spectrum indicated very little to no change in the enviroimient 
of tryptophan residues . Alternatively the difference spectrum obtained when the 
inhibitor was denatured in 6M guanidine hydrochloride showed the presence of a 
trough at 286nm, a shoulder at 282nm and another trough in 290-292nm range 
which was indicative of exposure of aromatic amino acid i.e. tyrosine and trypto-
phan respectively. Interestingly these observation were further confirmed by fluo-
rescence measurements. 
The fluorescence excitation and emission maxima of buffalo serum ai anti-
trypsin occured at 276 nm and 336 nm respectively. The maximum in the emission 
took place at somewhat lower wavelength than generally reported for tryptophan 
containing proteins (Cantor and Schimel, 1980) which was indicative of somewhat 
polar environment of the tryptophan residues in the buffalo serum ai antitrypsin 
Tryptophan fluorescence was used as an additional probe to study the 
environment of tryptophan residues present in buffalo serum aiantitrypsin. Meas-
urements were performed using excitation wavelength at 290 nm. Tryptophan flu-
orescence spectroscopic analysis indicated a blue shift in the emission maxima of 
the 9M urea denatured aiantitrypsin (335 nm) with respect to control (native Oian-
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titiypsin, 337nm) which was again indicative of no change in the environment of 
tryptophan residues present in buffalo serum ai antitrypsin even at 9M urea conce-
ntration. Further, a significant red shift was observed in the emission maxima of 
6M guanidine hydrochloride denatured aiantitrypsin (345 nm) with respect to con-
trol (337 nm) indicating exposed nature of tryptophan residues present in the inhi-
bitor and that guanidine hydrochloride acts as a more effective denaturant of a i an-
titrypsin than urea. 
The extent of exposure of tryptophan residues present in the buffalo serum 
ttiantitrypsin isolated in this thesis was determined by solvent perturbation diffe-
rence spectral studies both in 9M urea and 6M guanidine hydrochloride. As alre-
ady observed in this thesis that the isolated inhibitor has a very rigid structure 
(since it was found to be resistant to denaturation even in 9M urea) and the solv-
ent perturbation difference spectrum of protein at 292nm is attributed to perturb-
ation of their tryptophan residues (Laskowski Jr. 1966) denaturation of ai antitry-
psin in 9M urea suggest the presence of only 48% Of the tryptophan residues in 
exposed state , while denaturation of ai antitrypsin in 6M guanidine hydrochloride 
suggested about 75% exposure of tryptophan residues in native aiantitrypsin. That 
the buffalo serum aiantitrypsin has a rigid structure can now be said with more 
certainty because in spite of that fact that guanidine hydrochloride appears to be a 
stronger denaturant even then all of the tryptophan residues of the inhibitor cannot 
be said to be ftilly exposed to dimethyl sulfoxide the perturbing solvent used. 
As can be seen from the results that guanidine hydrochloride acts as a 
potent denaturant of buffalo serum aiantitrypsin a fact that was fiirther proved by 
measuring the decrease in fluorescence intensity over the entire range of urea and 
guanidine hydrochloride concentration measured at the emission maxima value 
(337nm) of the native buffalo serum aiantitrypsin . The greater decrease in the 
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fluorescence intensity observed in the presence of guanidine hydrochloride as 
compared to native inhibitor confirms that guanidine hydrochloride acts as a more 
potent denaturant than urea. 
The gradual change in the fo values of the buffalo serum ai antitrypsin as 
a function of urea and guanidine hydrochloride suggested the non-cooperative 
behavior of the process of unfolding. Such changes also suggest the role of addi-
tional denaturant molecule bound as a result of chromophore being exposed from 
the interior of the molecule to the bulk. The observation that has already been 
confirmed earlier during the course of this study. Interestingly it was observed 
during the denaturation curve analysis that in .pite of the fact that guanidine hydr-
ochloride acts as more potent denaturant than urea the AGD"2° values were found 
to be in excellent agreement which were 3.17 Kcal/mole in case of urea denatured 
buffalo serum aiantitrypsin while a value 3.41 Kcal/mole was obtained when guan-
idine hydrochloride was used as a denaturant. The denaturation curve analysis and 
activity profile measurements suggest that in case of guanidine hydrochloride the 
denaturation is complete at a little more than half the concentration as compared to 
urea. 
Circular dichroic spectral analysis suggests that the native buffalo serum 
tt] antitrypsin contains significant amount of secondary structure both a-hehcal 
and P-pleated sheet while slight changes were observed in the backbone confor-
mation in case of 9M urea denatured Oi antitrypsin while the backbone confor-
mation was found completely denatured in case of 6M guanidine hydrochloride 
denatured aiantitrypsin. 
That the isolated buffalo serum aj antitrypsin is competitive in nature like 
its human counterpart was proved by studying the stoichiometric binding of the 
inhibitor with trypsin and also by determining the Km and Vmax values. Stoichio-
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metric analysis showed that 0.80 moles of trypsin bind to one mole of inhibitor 
which is very close to 1:1 molar ratio indicating the that the inhibitor acts compe-
titively. The kinetic parameter values of free and inhibited trypsin show no change 
in Vmax values while Km value changes from 1.10 x 10"^  M of free trypsin to 2.0 
X 10"^  M of inhibited trypsin fiirther confirming that the isolated inhibitor is 
competitive in nature as already determined for human ai antitrypsin (Crawford, 
1973). 
It can be concluded on the basis of the studies carried out in this thesis 
that: 
(i) Buffalo serum aiantitrypsin has been isolated and purified by a very 
simple and gentle procedure. No extremes of pH or temperature, no expo-
sure to solvents distinguish this from previously reported methods. 
(ii) Buffalo serum ai antitrypsin obtained satisfied many criteria of homogene-
ity as it was found to be homogeneous both with respect to charge and 
size as shown by ion exchange chromatography, PAGE, SDS-PAGE, gel 
chromatography on Sephacryl S-200HR column as well as during HPLC 
gel filtration. 
(iii) The presence of a single band during SDS-PAGE both under reducing and 
non-reducing conditions predict a single chain structure of the native mol-
ecule. 
(iv) Buffalo serum aiantitrypsin was found to contain two free sulphydryl 
groups. 
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(v) Buffalo serum ai antitrypsin was observed to be a sialoglycoprotein conta-
ining about 2.6% sialic acid and 10.9% neutral hexose. 
(vi) Buffalo serum aiantitrypsin showed inhibitory specificity different from 
human aiantitrypsin. The former was observed to be a potent inhibitor of 
bovine trypsin and only a moderate inhibitor of elastase while the latter 
has been reported in earlier studies to be a potent inhibitor of elastase. 
The difference in the inhibitory specificities can be due to the differences 
in the amino acid sequence within the reactive site region. 
(vii) Interestingly, it was observed that though the buffalo serum aj antitrypsin 
contains both neutral hexose and sialic acid residues like its human coun-
terpart (reported in earlier studies), it (buffalo serum ai antitrypsin) shows 
inhibitory specificity different from human ai antitrypsin but similar to 
goat ai PI which has been reported earlier to be a glycoprotein devoid of 
sialic acid residue. Thus it can be said that sialic acid residues have no 
role to play in deciding the inhibitory behaviour of the inhibitor. 
(viii) Molecular weight of buffalo serum aj antitrypsin obtained by gel filtration 
was found to be about 9% higher than the molecular weight obtained by 
SDS-PAGE which can be attributed to the high content of carbohydrate 
residues in the molecule. 
(ix) UV difference specfra of buffalo serum aiantitrypsin obtained with urea 
or guanidine hydrochloride indicate that tryptophan residues were not exp-
osed when denatured in urea but were exposed when guanidine hydrochl-
oride was used. Thus guanidine hydrochloride can be said to be a more 
potent denaturant. 
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(x) Solven perturbation difference spectra indicate that irrespective of the den-
aturant used the tryptophan residues were only partially accessible to the 
solvent. The accessibility increases when guanidine hydrochloride was 
used as a denaturant. 
(xi) Tryptophan fluorescence results confirmed the conclusion derived from 
UV spectrum and solvent perturbation analysis. Denaturation of buffalo 
serum ai antitrypsin in 6M guanidine hydrochloride was observed to lead 
to a large red shift in the emission maxima as well as decrease in fluoresc-
ence intensity which were indicative of major conformational changes in 
the surrounding of the chromophore (exposure of tryptophan residues to 
the aqueous environment in the unfolded state). Similar results were obta-
ined when fluorescence intensity of the inhibitor was monitored at 337nm 
in the presence of varying amount of urea and guanidine hydrochloride. 
(xii) Of substantial interest was the observation that inspite of guanidine hydro-
chloride being a more potent denaturant AGD"2° values obtained both in 
case of urea and guanidine hydrochloride were found to be in excellent 
agreement. It was also observed that denaturation of inhibitor in guanidine 
hydrochloride was complete at a little more than half the concentration as 
compared to urea. 
(xiii) CD spectra of native buffalo serum ai antitrypsin compared with 9M urea 
denatured ai antitrypsin and 6M guanidine hydrochloride denatured a] ant-
itrypsin indicate that the native molecule consists of a high content of a-
helical and p-pleated sheet structure while the backbone conformation 
was slightly disorganised in 9M urea fiirther it was also observed that the 
backbone conformation was fully disorganised in 6M guanidine hydrochl-
oride. 
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(xiv) The results obtained during UV spectroscopy, activity measurements (in 
the presence of denaturants), solvent perturbation studies, fluorescence 
measurements, denaturation curve analysis and CD measurements indica-
ted that the buffalo serum aiantitrypsin has a fairly rigid and stable struct-
ure. 
(xv) That the buffalo serum ai antitrypsin acts as a competitive inhibitor has 
been been shown by the stoichiometric analysis of the inhibitor binding to 
trypsin in 1 : 1 ratio as well as from the values of kinetic parameters 
(Km and Vmax) obtained by double reciprocal plot. 
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